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1. INTRODUCTION 
 
The twelfth meeting of the WHOPES Working Group, an 
advisory group to the WHO Pesticide Evaluation Scheme 
(WHOPES), was convened at WHO headquarters in Geneva, 
Switzerland, from 8 to 11 December 2008. The objective of the 
meeting was to review the reports of testing and evaluation of 
BioFlash  GR, a Bacillus thuringiensis israelensis product of 
Nature Biotechnology Company (Islamic Republic of Iran) for 
mosquito larviciding, as well as those of four long-lasting 
insecticidal mosquito nets (LNs) for prevention of malaria: 
PermaNet  2.0; PermaNet  2.5 (=PermaNet  2.0 Extra); 
PermaNet  3.0 (Vestergaard Frandsen, Switzerland); and 
Lambda-cyhalothrin LN (=ICON  MAXX-Net) of Syngenta, 
Switzerland. 
 
The meeting was attended by 14 scientists (see Annex I: List of 
participants). Professor Dr Marc Coosemans was appointed as 
Chairman and Dr Purushothaman Jambulingam as Rapporteur. 
The meeting was convened in plenary and group sessions, in 
which the reports of the WHOPES supervised trials and 
relevant published literature and unpublished reports were 
reviewed and discussed (see Annex II: References).  
Recommendations on the use of the above-mentioned products 
were made. 
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2. REVIEW OF BIOFLASH  GR 
 
BioFlash  GR is a bacterial larvicide manufactured as a 
granular formulation by the Nature Biotechnology Company 
(Islamic Republic of Iran). The active ingredient (AI) is 
composed of viable endospores of Bacillus thuringiensis 
subspecies israelensis (Bti, serotype H-14) and delta-endotoxin 
crystals. The AI constitutes 10% of the formulated product, with 
a reported potency of 18 000 international toxic units (ITU)/mg. 
The manufacturer recommends a target dosage of 1.7 
kg/hectare of the formulated product. 
 
The human and environmental safety of Bt, including Bti, have 
been assessed by WHO (1999), 1  and no separate safety 
assessment has therefore been carried out on BioFlash GR. 
Application of any product formulated with Bti to potable water 
for the purposes of mosquito larviciding should be subject to a 
specific risk assessment, and should take into account 
microbial contaminants, formulants and impurities. Such an 
appraisal has not been part of the assessment provided 
hereunder.  
 
 
2.1     Efficacy – WHOPES supervised trials 
 
2.1.1   Laboratory studies 
 
Montpellier, France 
EID Méditerranée (2005) carried out bioassays with BioFlash 
GR (2005 batch) and VectoBac  12AS (Valent BioSciences, 
USA, 1200 ITU/mg) against late third-instar or early fourth-instar 
larvae of Aedes aegypti Bora-Bora strain and Culex 
quinquefasciatus S-lab strain. The potency of BioFlash GR was 
calculated by comparing its activity with that of the 
recommended international standard, IPS-82 (Bti, 15 000 ITU 
Ae. aegypti/mg) from the Pasteur Institute, France.  
 
The preliminary test used eight concentrations against Ae. 
aegypti and six concentrations against Cx. quinquefasciatus, 
                                                          
1  WHO (1999). Microbial pest control agent, Bacillus thuringiensis. 
Geneva, World Health Organization (Environmental Health Criteria 
217).  
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with two replicates for each dosage, to arrive at dosages that 
would provide 0–100% mortality. Subsequently, six 
concentrations of BioFlash GR (0.25–4.0 mg/L), five to six 
concentrations of VectoBac 12AS (0.06–0.36 mg/L) and five 
concentrations of IPS82 powder (0.0075–0.03 mg/L) were 
selected for testing against each species. Each concentration 
was tested in five replicates and a control. The BioFlash 
granules were weighed, placed in osmosed water with a small 
drop of wetting agent (Tween 80) and homogenized for 15 
minutes. The granules were separated on a filter and serial 
dilutions were made from the suspension. The IPS 82 powder 
was weighed, placed in osmosed water and homogenized in a 
blender; further dilutions were made from this primary 
suspension. The VectoBac suspension was dissolved in 
osmosed water and serial dilutions were made. Aliquots of 
aqueous dilutions were added to 99 ml of water in disposable 
cups containing 20 larvae.  
 
Twenty early-third instar larvae kept in a jar containing 20–30 
ml osmosed water were transferred into a cup containing 99 ml 
of osmosed water treated with the formulation. Temperature 
was maintained at 26 ºC or 28 ºC + 1 ºC throughout the 
experiment. Larval mortality was scored 24 hours after 
treatment and percentage mortality was corrected for control 
mortality using Abbott’s formula. The experiments were 
repeated three times on three different days. Probit regression 
analysis was done to calculate the LC50 and LC90 values as well 
as their 95% fiducial limits. The potency of the test substance 
was calculated as follows: 15 000 ITU x LC50 standard 
IPS82/LC50 test substance. 
 
The LC50 and LC90 values indicate that BioFlash GR was 
relatively less active against Ae. aegypti and Cx. 
quinquefasciatus, (1.0378 mg/L and 2.1871 mg/L; 1.6279 mg/L 
and 3.0232 mg/L) compared with VectoBac 12AS (0.1202 mg/L 
and 0.1977 mg/L; 0.1600 mg/L and 0.3140 mg/L) and IPS82 
(0.0132 mg/L and 0.0237 mg/L; 0.0141 mg/L and 0.0278 mg/L). 
The potency of VectoBac 12AS against Ae. aegypti was 1646 
ITU/mg and that of BioFlash GR was 191 ITU/mg, about 100 
times lower than that reported by the manufacturer.  
 
Montpellier, France 
Bioassays were carried out in 2006 on samples of the same 
batch (no. 850085) of BioFlash GR sent for WHOPES field 
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testing and evaluation in Thailand, India and the Islamic 
Republic of Iran (EID Méditerranée 2006b). This included the 
determination of the potency and larvicidal activity of BioFlash 
GR against third-instar larvae of Ae. aegypti Bora-Bora strain 
(Lagneau et al., 2006). The ITU value was calculated by 
comparing its activity with that of the international standard, 
IPS-82 (Bti, 15 000 ITU Ae. aegypti /mg).  
 
Initially, five concentrations were used, with two replicates for 
each dosage, to arrive at dosages that would provide 0–100% 
mortality. Subsequently, six concentrations of BioFlash GR 
(0.25–3.0 mg/L) and IPS-82 powder (0.005–0.03 mg/L) were 
tested. Each concentration was tested in five replicates and 
equal number of control. Procedures followed for the 
preparation of suspension and larval testing were identical with 
described above.  
  
The LC50 and LC90 values were 0.01126 mg/L and 0.02218 
mg/L for IPS 82 and 1.66639 mg/L and 3.32804 mg/L for 
BioFlash GR, respectively (Table 1). The potency of BioFlash 
GR was equivalent to 101 ITU/mg, which was much lower than 
that obtained in 2005 (191 ITU/mg). This variation is probably 
due to differences in the preparation of two batches of the 
product. 
 
Montpellier, France 
EID Méditerranée (2006a) carried out a simulated indoor trial in 
130-L glass aquaria (1m x 0.33m: 0.33 m2) to evaluate the 
larvicidal activity and persistence of BioFlash GR (2005 batch: 
191 ITU/mg Ae. aegypti and 130 ITU/mg Cx. quinquefasciatus) 
in comparison with VectoBac® CG (Valent BioSciences, USA, 
200 ITU/mg) against late third-instar or early fourth-instar larvae 
of Ae. aegypti (Bora-Bora strain) and Cx. quinquefasciatus (S-
Lab strain). The aquaria were filled with 100 litres of tap water 
and placed in a room allowing a natural photoperiod. The 
contamination of the aquaria was tested by introducing 10 third-
instar larvae of Ae. aegypti or Cx. quinquefasciatus, S-Lab 
strain, 72 hours after the addition of water to the aquarium and 
recording the mortality 24 h after the addition of mosquito larvae. 
 
Four replicates were set up for each test species and the 
biocides were applied at 56.1 mg/aquarium (0.33m2), equivalent 
to the recommended dosage of 1.7 kg/ha for BioFlash. One 
aquarium was kept as a control for each species. The efficacy 
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was evaluated by introducing 50 third-instar larvae of Ae. 
aegypti or Cx. quinquefasciatus in each aquarium, 24 hours 
before the treatment and recording mortalities 72 hours after 
the treatment. The residual activity was determined by 
introducing 50 third-instar larvae into each aquarium from day 3 
post-treatment and recording mortalities 48 hours post-
treatment. From day 3 post-treatment, 10 litres of water were 
removed daily for 5 days each week until termination of the 
experiment. The aquaria were replenished with 50 litres of 
water on day 5. The experiment was terminated after 94 days. 
The air and water temperatures were 25.06 ºC +/– 0.06 ºC and 
23.03 ºC +/– 0.08 ºC, respectively. The mean water pH value 
was 7.75, and the mean conductivity was 577.5 mS/cm and 02 
11.6 mg/L. 
 
In the aquaria, BioFlash GR provided 96–100% reduction of Ae. 
aegypti larvae up to 94 days post-treatment; VectoBac CG gave 
82.5–100% reduction up to 80 days post-treatment. The 
larvicidal efficacy of VectoBac CG was significantly lower than 
that of BioFlash GR (Wilcoxon’s test, p <0.01). The reduction of 
Cx. quinquefasciatus larvae was 86.5–100% in the aquaria 
treated with BioFlash GR and 67–100% in the aquaria treated 
with VectoBac CG for 94 days post-treatment. Until day 59 
post-treatment there was no significant difference in the activity 
of the two formulations. Thereafter, VectoBac CG was found to 
be less active than BioFlash GR (Mann-Withney test).  
 
 
2.1.2 Field studies 
 
Nonthaburi, Thailand 
Mulla et.al. (2007) evaluated the initial and long-term efficacy of 
BioFlash GR against Ae. aegypti larvae in Nonthaburi, Thailand, 
in comparison with VectoBac1 WG (Valent BioSciences, USA, 
3000 ITU/mg), which is used in mosquito control programmes. 
Two types of containers were used: 200-litre capacity earthen 
water-storage jars (used commonly by households) and 70-litre 
capacity plastic barrels.  
 
Before testing, both types of containers were decontaminated 
by filling them fully with water and setting them open in the sun. 
The containers were then emptied, scrubbed, rinsed thoroughly 
                                                          
1 VectoBac WDG (water dispersible granule). 
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with water and dried in the sun or shade for a day or two. The 
containers were placed on a concrete slab under a roof, where 
the area was open on all sides, simulating field conditions. The 
jars and the plastic containers were filled to capacity with 200 
litres and 70 litres respectively of domestic tap water. The filled 
earthen jars had a water column height of 62 cm; when half-full, 
the water depth was 32 cm. The diameter of the jar at the water 
surface was 44.5 cm. The mouth of the jars was kept covered 
with celocrete sheets at all times except during the removal and 
addition of larvae. The 70-litre plastic barrels had a water 
column 56 cm when full; the diameter of the barrel at the water 
surface was 41 cm. The barrels were covered with a lid 
provided with a circular mesh screen of 16 cm diameter for 
ventilation. Into the water were placed 25 laboratory-reared 
third-instar larvae of Ae. aegypti and their survival scored 2 or 3 
days later. This procedure was done for up to 6 weeks. Those 
jars or barrels giving 20% or greater mortality were excluded 
from the tests or cleaned further. The contaminated jars were 
washed, scrubbed and retested until they were fit for the 
experiments. 
 
In a preliminary test to find the range of activity of BioFlash GR, 
two jars each were treated with high dosages of 100, 200 and 
300 mg/L of BioFlash GR. Observation of the activity and 
floating capacity of the formulation was made for 3 weeks. 
Although all the dosages caused 100% mortality of larvae, 
dosages of 200 mg/L and 300 mg/L caused significant scum 
formation and an oily film that trapped the granules. Therefore, 
100mg/L or lower dosages were used in the tests. 
 
Each type of container and each treatment had four replicates 
and an equal number of controls. Two regimens of water were 
used in the earthen jars: jars that were full at all times and jars 
from which half of the water was removed and replenished 
weekly after the initial 3-week observation. Since some of the 
BioFlash GR floated for 3 weeks, the water was not emptied or 
replaced for 3 weeks. An electrical pump lowered to midway in 
each earthen jar was used for removing the water in the 
experiments with half-full water. Thermometers were placed in 
each of the control jars and barrels and the temperature 
recorded at each assessment interval.  On average, water 
temperatures during the test ranged from 28 °C to 34 °C. 
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Before treatment, 25 third-instar laboratory-reared Ae. aegypti 
larvae were placed into a cup with a small amount of water and 
transferred to the jars or barrels. Ground larval food (1 g) was 
added to each container and 0.5 g was then added each week.  
The required amounts of BioFlash GR were weighed and 
spread over the water surface of the containers. Most of the 
granules floated on the surface for a week. The water surface 
was stirred gently with a spoon to make the granules sink to the 
bottom. Different dosages of the WG formulation were 
suspended in water and 10 ml of the suspension of a given 
dose was pipetted onto the water surface and gently stirred. 
After treatment, the jars and barrels were kept covered. 
 
To determine the duration of efficacy, every week new cohorts 
of Ae. aegypti larvae were added to each container. For one 
month, larval and pupal mortality was assessed 72 hours after 
the addition of larvae. To assess the emergence of adult 
mosquitoes, 1 week after the addition of the larvae, pupal skins 
indicating successful emergence were removed by suction and 
counted in water in white trays. The reduction of emergence 
was calculated based on the initial number of larvae released. 
Correction of reduction of emergence to the control was not 
done as control mortality was mostly in the low range. The 
evaluation was carried out for about 3 months after a single 
treatment.  
 
BioFlash GR was used at four dosages (10, 20, 50 and 100 
mg/L) of the formulation in full jars and three dosages (20, 50 
and 100 mg/L) in half-emptied jars. In full jars, BioFlash GR at 
10, 20, and 50 mg/L formulation gave 80–100% reduction for 
42–49 days post-treatment. The higher dosage (100 mg/L) 
provided 96–100% reduction up to 85 days post-treatment, i.e. 
until the end of the experiment. These high dosages are, 
however, not practically feasible because of the excessive 
floatage of oily film on water surface and their high cost.  
 
The efficacy of BioFlash GR was slightly higher and it and 
longevity was longer in jars where half of the water was 
removed and replaced weekly. The low dosage 20 mg/L gave 
87–100% reduction up to 49 days post-treatment, 50 mg/L gave 
93–100% up to 70 days post-treatment and then declined below 
80%. The higher dosage (100 mg/L) provided 100% control up 
to the end of the experiment (Table 2). This indicated that water 
removal and replenishment stir up the granules present at the 
 8 
bottom of the jars, facilitating release and distribution of the 
toxins in the water medium. 
 
VectoBac WG was applied at much lower rates using four 
dosages (0.25, 0.5, 1.0 and 2.0 mg/L). In jars without water 
removal, 0.25 mg/L formulation yielded 82–100% reduction for 
35 days post-treatment. The next dosage (0.5 mg/L) gave 97–
100% reduction for 35 days, declining to <80% 42 days post-
treatment. The next higher dosage (1.0mg/L) gave >90% 
reduction for 35 days and >80% for 56 days. The highest 
dosage (2mg/L) yielded >90% reduction up to the end of the 
experiment i.e. at 85 days post-treatment (Table 2). The higher 
the dosage, the greater the efficacy and longevity. 
 
The efficacy of VectoBac WG was lower and its longevity was 
shorter in half-filled earthen jars with the water removed and 
replenished weekly, than the constantly full jars. The lowest 
dosage used (0.5 mg/L) gave 92–100% reduction for 21 days, 
declining to 59% on day 28. The next high dosage (1.0 mg/L) 
gave 80–100% reduction for 35 days post-treatment. The 
highest dosage of 2.0 mg/L gave 85–100% reduction for 35 
days post-treatment. 
 
The plastic barrels were constantly full without water removal 
and replenishment. Although 20 and 50mg/L dosages gave 80–
100% reduction for  42 and 56 days respectively, 10 mg/L and 
100 mg/L yielded reduction only for 35 days. The short duration 
of efficacy of BioFlash GR in the barrels is probably a result of 
sunlight entering the barrels from the screened lids. Towards 
the end of the experiment (63 days post-treatment), the barrels 
were invaded by the corixid predator, Micronecta, through the 
screened lids, but the efficacy of the formulations had already 
declined below 80%. 
 
In contrast to BioFlash GR, VectoBac WG showed high efficacy 
and longevity in the barrels. The two low dosages (0.25 and 0.5 
mg/L) gave 80–100% for 49 days, while the high dosages (1.0 
and 2.0 mg/L) yielded 85–100% control for up to 70–77 days 
post-treatment.  
 
Another experiment was carried out in full earthen jars without 
water removal and replenishment using further low dosages (1, 
2.5 and 5 mg/L) of BioFlash GR formulation. All three dosages 
gave 100% reduction or Inhibition of emergence (IE) for 6 days 
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post-treatment, the two lower dosages gave >80% for 20 days 
and  the highest dosage (5 mg/L formulation) gave >85% 
control for 27 days post-treatment (Table 2).  
 
The WG formulation at the three higher dosages killed larvae 
within 1 hour after addition. The lower dosage killed larvae 
within 24 hours. BioFlash GR killed larvae slowly and by 24 
hours only.  
 
The BioFlash GR formulation appears to be based on corn grit 
or similar inert material. However, the size of the particles is 
very heterogeneous with fines, some being very large and 
some very small. Moreover, they are flaky and have a fine 
texture not suitable for field application. When applied to water, 
the particles stick together, floating on the surface. Some were 
seen floating for 3–4 weeks, a feature not desirable. One month 
after treatment, most granules sank to the bottom and were still 
visible there 3 months after treatment. 
 
Ghassreghand, Sistan and Baluchistan, Islamic Republic of 
Iran 
The efficacy and residual activity of BioFlash 10%GR were 
tested against Anopheles and Culex larvae in artificial ponds in 
comparison with Reldan (22.5% EC), the larvicide used in a 
malaria control programme in the south of the Islamic Republic 
of Iran (Ladonni, 2006). 
 
The ponds (100 x 100 cm; depth 50 cm) were dug at about 
1 metre apart, lined with plastic sheeting and filled with soil or 
mud from the breeding sites of target vector species to a depth 
of 10 cm. The ponds were filled with water from the same 
habitat to a depth of 30 + 5 cm and were allowed to remain for 2 
weeks until oviposition occurred. Treatments were undertaken 
when adequate numberd of third-instar and fourth- instar larvae 
and a few pupae started appearing in the ponds. The water 
level was maintained throughout the trial period. In order to 
avoid adult emergence, mature pupae were removed daily. 
 
BioFlash GR was tested in two phases. In the first phase, 
Bioflash was used at three application rates (0.85, 1.7 and 3.4 
kg/ha) in order to find the efficacy range at one dosage above 
and one below the dosage recommended by the manufacturer. 
As there was no desired level of reduction of larval density at 
these dosages of BioFlash, three dosages much higher than 
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the recommended dosage (6.8, 15 and 30 kg/ha) were used. In 
both the phases, Reldan (22.5% EC) was used at 400 ml /ha. 
Each dosage and control was replicated four times. Reldan EC 
was applied using a hand-compression sprayer with a flat fan 
nozzle, while the GR formulation was broadcasted by hand 
(with gloves). 
 
Larval and pupal densities were monitored before treatment 
using dipper sampling and thereafter at one-day intervals during 
the post-treatment period until the density had reached the pre-
treatment level. Species composition was determined by 
bringing fourth-instar larvae from untreated breeding places and 
identifying them in the laboratory. The percentage reduction in 
the density of larvae and pupae was calculated using the 
Mulla’s formula. The percentage reduction of late-instar larvae 
was used as the main indicator. 
 
The following species composition was recorded: An. 
culicifacies (45.2%), An. stephensi (28.9%), An. dethali (12.2%), 
An. superpictus (9.6%) and An. sergenti (4.1%); Cx. 
tritaeniorhynchus (46.2%), Cx. pipiens (31.9%), Cx. 
pseudovishnui (15.2%) and Cx. quinquefasciatus (6.7%). 
 
The percentage reduction was <50% during the post-treatment 
period at 0.85 kg/ha, 1.7 kg/ha & 3.4 kg/ha for both Anopheles 
and Culex larvae. While the reduction at 6.8 kg/ha was <50%, 
the maximum reduction was <60% at 15 kg/ha post-treatment. 
Even at 30 kg/ha, >80% mortality was obtained only on day 5 
and day 7 post-treatment (Table 2), indicating that the 
formulation provided at this high dosage was an effective 
control for a short period of 3–4 days only.  
 
Reldan EC at 400 ml of formulation/ha gave 80–100% of pupal 
and larval reduction up to 15 days. 
 
Delhi, India 
BioFlash 10%GR was evaluated against larvae of An. stephensi 
breeding in cement tanks with fresh water, Cx. quinquefasciatus 
in cement tanks and surface drains with organic matter and An. 
subpictus in rainwater pools in two locations around Delhi (Adak 
et al., 2007).  
 
Initially, larval and pupal samples were brought from the 
habitats to the laboratory. Adults that emerged from the 
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samples were identified and the selection of habitats was then 
made. The surface area of cement tanks ranged from 0.62 m2 
to 3.6 m2 and that of the drains from 50 m2 to 100 m2. The size 
of the rainwater pools varied from 9.0 m2 to 25 m2. Total surface 
area of the breeding habitats of An. stephensi treated with 
BioFlash GR was 32.4 m2, that of Cx. quinquefasciatus was 
518.63 m2 and that of An. subpictus was 86 m2. The total area 
of untreated habitats was 14.4 m2, 200 m2 and 29 m2, 
respectively for the three mosquito species. Each of the cement 
tanks or drains was considered as a discrete site for replication 
of treatment or control.  pH and other characteristics of the 
habitats were recorded.  
 
The pre-treatment density of immature mosquitoes was 
monitored in experimental and control habitats using a standard 
larval dipper (300 ml volume, 9 cm diameter). A number of 
serial dips were made in drains. Larval instars and pupae 
collected in sampling dips were counted and larvae classified 
into early (I–II instars) and late (III and IV) instars.  
 
Three dosages of BioFlash (1.36, 1.7 and 2.04 g/m2, equalling 
13.6, 17.0 and 20.4 kg/ha) were applied to cement tanks with 
fresh water. Eight incremental dosages (0.06, 0.17, 0.34, 0.68, 
1.02, 1.36, 1.7, 2.04 g/m2, equalling 0.6, 1.7, 3.4, 6.8, 10.2, 13.6, 
17.0 and 20.4 kg/ha) were applied in cement tanks with water 
containing the organic matter. The rainwater pools were treated 
at 2.04g/m2 (20.4 kg/ha). The formulation was applied to the 
larval habitats uniformly by hand broadcasting (wearing gloves). 
 
Larval densities were measured in all habitats on days 1, 2, 3 
and 7 post-treatment and thereafter weekly until the larval 
counts in the experimental sites reached the level present in the 
control habitats. The mean number of III–IV instar larvae 
collected per dip from each habitat was calculated for each day 
of observation. The percentage reduction in larval densities 
post-treatment was calculated using Mulla’s formula (1971). 
 
The highest reduction of An. stephensi larval density in cement 
tanks with fresh water was 30% 2 days after application of 
BioFlash GR at 1.36g/m2 with no control in succeeding intervals. 
At 1.7 g/m2, reduction of this species ranged between 37.9% 
and 74.1% during the 2 weeks post-treatment. At 2.04 g/m2, the 
efficacy increased only to 84.7% on days 2–7 post-treatment, 
declining thereafter (Table 2).  
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In the cement tanks with water containing organic matter, the 
reduction of Cx. quinquefasciatus larval densities at the 
dosages up to 1.7g/m2 was <66.3% during 2 weeks of follow up. 
With the highest dosage (2.04 g/m2), the maximum reduction in 
larval counts was 86.4% on day 14 post-treatment with 
reductions <60% on days 1–7 post-treatment. In drains, only 
the highest dosage (2.04 g/m2) was evaluated and the 
maximum reduction in larval densities was >80% at days 7 and 
14 post-treatment after which the efficacy declined. 
 
In rainwater pools, treatment at 2.04g/m2 of BioFlash reduced 
the larval density of An. subpictus by 92–93%, on days 7 and 
14 post-treatment.  However, the reduction was <60% on days 
1 and 2 post-treatment. 
 
 
2.2     Conclusions and recommendations 
 
BioFlash  GR is a granular formulation containing the microbial 
agent, Bacillus thuringiensis subspecies israelensis (Bti, 
serotype H-14) at the concentration of 10%. The product is 
manufactured by the Nature Biotechnology Company (Islamic 
Republic of Iran). The product has been primarily developed for 
the control of Anopheles larvae that feed at the surface of the 
water. The formulation is capable of floating on the surface of 
water for a relatively long period.  
 
The manufacturer reports that the AI constitutes 10% of the 
BioFlash GR formulation.  The bio-potency of the AI is reported 
as 18 000 ITU/mg (i.e. 1800 ITU/mg for the formulated product). 
However, in WHOPES supervised laboratory studies, the 
formulation was found to have potency in the range of 101–191 
ITU/mg, i.e. about 10–18 times lower than that reported by the 
manufacturer for the formulated product. The product is 
recommended by the manufacturer at the target dosage of 1.7 
kg/ha. 
 
The WHOPES supervised field trials were carried out with the 
samples of BioFlash GR with 101 ITU/mg. The trial in Thailand 
was carried out against Ae. aegypti larvae in earthen jars (200 L 
water) and plastic barrels (70 L water) for a period of 3 months. 
BioFlash GR at the high dosages of 20–100 mg/L provided 
>80% control for about 7–12 weeks, irrespective of the type of 
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container and the water usage pattern.  The study in the Islamic 
Republic of Iran, carried out in artificial ponds against 
Anopheles and Culex mosquito populations, showed that even 
at very high dosages (15 and 30 kg/ha), the residual activity 
was much shorter, ranging from 4 to 7 days. The study in India 
was carried out against Anopheles breeding in cement tanks 
with fresh water, Anopheles and Culex species breeding in 
cement tanks and drains containing water with organic matters, 
and Anopheles species breeding in rainwater pools. BioFlash 
GR provided control of mosquito larvae for 7–14 days only at 
the high dosage (20.4 kg/ha).  It is clear that BioFlash GR, 
having efficacy in water storage containers placed in shade and 
with covers, manifested only short-term efficacy in open, 
outdoor habitats. 
 
During the course of evaluation, it was noted that BioFlash GR 
is heterogonous in terms of particle size, with a considerable 
amount of fine particles. While the floating feature of the 
particles on the water surface is important for Anopheles control, 
it is not a desirable attribute for use in water storage containers.   
 
Noting the above, it is recommended: 
 
- that the manufacturer develops a more cost-effective 
formulation and revises the product label in 
accordance with the product's potency and 
recommended application dosage. The content of 
the AI should be declared in ITU/mg and when 
determined by the method described in WHO 
guidelines,1 the average bio-potency should not be 
less than 90% of the declared minimum content. 
 
 
 
 
                                                          
1 FAO/WHO (2006). Manual on development and use of FAO and 
WHO specifications for pesticides – March 2006 revision of the first 
edition (available at: 
http://whqlibdoc.who.int/publications/2006/9251048576_eng_update2.
pdf; accessed January 2009). 
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3. REVIEW OF PERMANET  2.0 
 
PermaNet  2.0 is a deltamethrin-coated LN manufactured by 
Vestergaard Frandsen (Switzerland). The net is made of knitted 
poly-filament polyester fibres and is treated with deltamethrin to 
a target concentration of 55 mg/m2 (= 1.4 g/kg for a 100-denier 
net; 1.8 g/kg for a 75-denier net). The insecticide is bound in a 
resin coating that reduces the amount of insecticide lost during 
routine washing. The PermaNet 2.0 received WHOPES interim 
recommendations in 2004;1WHO specifications for its quality 
control and international trade were published in 2006.2  
 
PermaNet 2.0 has been widely distributed and used in many 
countries since 2004. However, large-scale longitudinal 
randomized household trials, as required by WHOPES for 
Phase III evaluation of LNs, is limited to one published study.3 
Published information on monitoring and evaluation of 
PermaNet 2.0 under operational settings is also not available. 
Therefore, a series of cross-sectional surveys were carried out 
in different sites in six African countries to generate more 
information on the efficacy and durability of the PermaNet 2.0. 
The present assessment includes a review of relevant 
background information as well as the results of the multi-
country surveys. 
 
 
3.1 Efficacy – background and supporting documents 
 
Several studies on PermaNet 2.0 have been published since 
the interim recommendation given in 2004. However, only two 
studies in which PermaNet 2.0 had been in household use for 
                                                          
1  WHO (2004). Report of the seventh WHOPES Working Group 
Meeting, WHO/HQ, Geneva, 2–4 December 2003 (available at 
http://www.who.int/whopes/recommendations/wgm/en/; accessed 
January 2009). 
2 WHO (2005) WHO specifications for pesticides used in public health 
(available at: http://www.who.int/whopes/quality/newspecif/en/; 
accessed January 2009). 
3 Testing and evaluation of public health pesticides by WHOPES are 
carried out at the request of industry. Time-limited (4-year) interim 
recommendations were introduced by WHOPES only in 2006, giving 
WHO the possibility of withdrawing its interim recommendations in the 
absence of data or information needed to develop full 
recommendations.   
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at least three years have been published. Kroeger et al. (2004) 
reported on the efficacy of PermaNet 2.0 in Colombia. This 
study was not considered in this report because no follow-up 
activity on the use of the nets between the first and third years 
was reported, the cone assay test did not conform with the 
WHO standard, only four nets were assessed and no controls 
were included. 
 
Kilian et al. (2008) reported on the efficacy and durability of 
PermaNet 2.0 in a randomized household trial in Uganda. 
Although initiated before the publication of WHOPES guidelines, 
this study largely conformed to WHOPES guidelines, with only 
minor differences, and hence was used in this assessment. 
 
The PermaNet 2.0 was compared with conventionally-treated 
nets in a randomized double-blind study design in Kyenjojo 
District, west Uganda (Kilian et al., 2008). A total of 140 
conventionally-treated nets and 260 PermaNet 2.0 were 
distributed for this study.    The conventional nets were initially 
distributed in 2001 and were re-treated in 2002 when the 
PermaNet 2.0 was distributed.  No specific instructions 
regarding use or washing were given to the net users.  Nets 
were followed up at regular intervals to administer a 
questionnaire on net use, care and perception and to assess 
physical net condition.  Seven surveys of net use and condition 
were done over the course of the study.  A random sample of 
10 nets was taken at baseline and random samples of 40 nets 
per treatment arm were taken five times over the course of 
three years. 
 
A 30 x 30 cm sample of netting was taken from each net for 
bioassays, while a 10 x 10 cm sample was taken for chemical 
analysis.  WHO cone bioassays with a 3-minute exposure time  
were carried out using 40 female Anopheles gambiae s.s. per 
net sample.  In most cases, only one sample per net was tested.  
For chemical analysis, samples were extracted by heating 
under reflux for 60 minutes in xylene; deltamethrin content was 
assayed by capillary Gas Chromatography using 63Ni Electron 
Capture Detection (GC-ECD) and external standard calibration.  
The analytical method used was successfully validated and 
showed good accuracy and precision. 
 
At each follow-up, all net owners were visited and asked about 
net use, washing frequency and washing method.  The majority 
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of nets were observed hanging over their sleeping space at the 
time of the surveys.  Daily use was reported to be 95% 
throughout all seven surveys.  All but two out of 2510 washes 
reported were done using cold water and country soap.  It was 
estimated that nets were washed on average 1.8 times per year. 
 
The proportion of nets with at least one hole rose rapidly after 
distribution to just under 50% within one year and >80% after 
three years.  Each hole was categorized as small (the size of a 
coin), medium (up to the width of a person’s hand) or large 
(larger than the width of a person’s hand).  A hole index was 
estimated by multiplying the number of holes in each category 
by 1 (small), 2 (medium) or 3 (large).  The mean hole index was 
estimated at each time point for each study arm, including nets 
with no holes.  Average hole index increased linearly up to an 
index of 15 after three years of use. 
 
The median PermaNet 2.0 baseline concentration was 
69.2 mg/m2 (56.8–75.4), which is just above the acceptable 
range of 55 mg/m2 + 25%.  After 36 months, average 
deltamethrin concentration on the PermaNet 2.0 was 
28.7 mg/m2 (41.5% of baseline dose).  In contrast, deltamethrin 
concentrations on the conventionally re-treated nets fell from 
42.8 mg/m2 at baseline to 1.4 mg/m2 after 12 months of routine 
use. 
 
In the cone bioassays, knock-down was >95% at all time-points 
except for nets collected after 24 months post-distribution, 
where knock-down was 92.4%.  Similarly, mortality was >80% 
at all time-points except for nets collected at 24 months post-
distribution, when mortality was 73.9%.  After 36 months of 
follow up, 90% of nets had either a knock-down rate >95% or 
mortality rate >80%.  More than 90% of nets tested at each 
time-point met the WHOPES criteria for the cone test, except 
for nets collected at 24 months post-distribution, when only 71% 
of nets met the WHOPES criteria for the cone test. 
 
The authors concluded that the PermaNet 2.0 showed excellent 
results after three years of routine household use and fulfilled 
the WHOPES criteria for an LN. 
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3.2 Efficacy – WHOPES supervised study 
 
In a multi-country survey carried out by WHOPES in 2007–2008, 
in collaboration with the WHO Global Malaria Programme, 
PermaNet 2.0 net samples were taken from different sites in six 
African countries: Angola, Ghana, Kenya, Madagascar, Togo 
and Zambia. The selection of sites in each country was based 
on the information provided by the manufacturer as well as on 
information provided by WHO regional offices, and where the 
distribution, age and use of the nets could be verified. 
Collection of net samples was not limited to a specific delivery 
or distribution mechanism. Sites where PermaNet 2.0 nets aged 
between 1 and 3 years could be obtained and where nets were 
likely to be used year-round were selected for sampling. To 
achieve a sample that was as representative as possible, at 
least three sites were used in each country for collection of 
each category of net samples.  
 
Sites were initially selected by the ministries of health (MOH), 
and final selection of sites was done together with the MOH and 
local partners.  Within each selected site, all households were 
enumerated and randomly assigned to a specific order.  
Households were visited in order of selection, and owners of 
PermaNet 2.0 that had not been re-treated were asked to 
exchange their old net for a new PermaNet 2.0.  This continued 
until the required sample size was obtained.  If more than one 
PermaNet 2.0 was found in a selected household, one net was 
randomly selected. A questionnaire to assess use and washing 
behaviour was administered in households where PermaNet 
2.0 was collected (see Annex III). 
 
Sampled nets were returned to a central site in each country 
where they were hung over a frame and subjected to physical 
inspection, following the requirements specified in the data 
recording form (see Annex III). Upon completion of the 
inspection, subsamples were taken from each net for bioassays 
and chemical analyses. A unique five-digit code (first two for the 
country, third for the village and the last two digits for the net 
sample) was used to identify each net.  
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Bioassays 
A total of 466 PermaNet 2.0 nets were collected (Table 3) and 
dispatched to the WHO Collaborating Centre in Montpellier1 
(LIN/IRD) (Zumbo et al., 2008). Each net was identified with its 
five-digit survey code. Approximately one-third of the nets from 
each country and each year were randomly selected by the 
Collaborating Centre for WHO cone bioassay. For Kenya only, 
one-year-old nets were available. The following number of nets 
were subjected to cone bioassays: 
 
- 7 nets of one year old from each of the six countries,  
i.e. a total of 42 nets; 
- 8 nets of two years old from each of the five 
countries,  i.e. a total of 40 nets; 
- 12 nets for three years old from each of the five 
countries, i.e. a total 60 nets. 
 
A total of 142 nets were subjected to WHO cone bioassay. Four 
samples per net were tested. The net samples were taken from 
positions 2, 3, 4 and 5 (see Figure 1, Annex III). Position 1 was 
ignored as it may have been subjected to excessive abrasion 
and is the part that is supposed to be tucked under the mattress. 
 
Two-to-five-day-old, non-blood fed females of Anopheles 
gambiae s.s (Kisumu strain) were used for bioassays. This is a 
standard susceptible strain originally colonized in western 
Kenya.  It has been maintained in colony for many years at 
LIN/IRD and is free of any detectable insecticide resistance 
mechanism. The susceptibility of the strain is checked every 3 
months using PCR and biochemical assays. 
 
Per net, the pooled results of mortality and knock-down over the 
four samples were used to determine if a net was within the 
WHO requirement, i.e. >80% mortality and/or >95% knock-
down. Three-year-old nets that were not within the WHO criteria 
were subjected to the tunnel test. Only one sample per failed 
net was selected for tunnel test. The sample used in the tunnel 
test was the one where mortality was closest to the average 
mortality in the cone bioassay. The WHOPES criteria for the 
tunnel test are >80% mortality and or >90% blood-feeding 
                                                          
1 Laboratoire de Lutte contre les Insectes Nuisibles (LIN), Institut de 
Recherche pour le Développement (IRD), Montpellier, France. 
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inhibition1. Results of cone and tunnel tests were used together 
to judge on the net performance.  
 
The mean number of Anopheles gambiae (Kisumu) tested per 
net was 25, with a minimum of 17 and a maximum of 39. 
Figures 1 and 2 give on overview of the variation of mortality 
and knock-down as observed in cone test for the different 
countries and years. 
 
After one year, 98% of the nets met the WHO requirements 
based on the cone bioassay, decreasing to 85% and 57% in 
years 2 and 3 respectively (Table 4). Among the 26 three-year-
old net samples (43%) that failed WHO cone bioassays, 61% 
were effective in tunnel tests based on mortality (>80%) and/or 
blood-feeding inhibition (>90%). Overall, 80% of three-year-old 
nets met the WHO requirements for either the WHO cone test 
or the tunnel test. Large differences were observed among 
countries: nets collected in Ghana and Madagascar failed to 
meet the WHO criteria of an LN, whereas in Angola all nets 
fulfilled the requirements (Table 4).  
 
Chemical assay 
Chemical assays were conducted (Pigeon 2008a and 2008b) 
following a method based on the CIPAC method 333/LN/M/3 for 
determination of deltamethrin in PermaNet, i.e. extraction by 
sonication and shaking with isooctane/dioxane (80/20, v/v) and 
chromatographic determination by gas chromatography with 
flame ionization detection (GC-FID).  Results are given in the 
actual measurement (g/kg). The density of all net samples was 
assessed (Pigeon 2009a) to determine the denier, as this 
information was not available.  
 
A total of 420 nets were analysed: 61 from Angola, 80 from 
Ghana, 26 from Kenya, 85 from Madagascar, 90 from Togo and 
78 from Zambia (Table 3). After one year of net use, a 
significant loss of deltamethrin was observed in all countries 
compared with the baseline deltamethrin content of a 75 or 100 
denier net (Figure 3). The deltamethrin content dropped further 
during the next two years and was at the quantification limit of 
                                                          
1 WHO (2005). Guidelines for laboratory and field testing of long-
lasting insecticidal mosquito nets. Geneva, World Health Organization 
(WHO/CDS/WHOPES/GCDPP/2005.11; available at 
http://www.who.int/whopes/guidelines/en/; accessed January 2009). 
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0.2 g/kg in Madagascar. In Angola, no changes in deltamethrin 
content were observed over the three years (Figure 3). The 
measured deltamethrin content was highly variable between 
nets and countries.  Overall (all countries combined), the 
deltamethrin content decreased from a mean value of 
0.821 g/kg (95% CI, 0.723–0.920) in year 1, >0.558 g/kg 
(95% CI, 0.491–0.626) in year 2 to 0.431 g/kg   (95% CI, 0.367–
0.495) in year 3. The overall mean deltamethrin content of a 
one-year-old net was 45% and 60% of the baseline 
concentration for a 75- and 100-denier PermaNet 2.0 
respectively. A three-year-old net had a mean deltamethrin 
content of 24% and 31% for a 75- and 100-denier PermaNet 
2.0 respectively. 
 
The correlation between the chemical analysis and the cone 
bioassays on adjacent pieces of netting shows that low 
deltamethrin concentrations (even below the quantification limit) 
can still cause mortality above the threshold of 80%. Likewise, 
the high knock-down values were observed for nets with 
variable deltamethrin content (Figure 4). The mean deltamethrin 
content of nets causing <80% mortality was 0.274 g/kg (95% CI, 
0.235–0.314) and causing <95% knock-down was 0.241 g/kg 
(95% CI, 0.193–0.289). 
 
All nets that failed (cone tests and tunnel tests combined; Table 
4) had a deltamethrin content <0.2 g/kg, which is the 
quantification limit of the analytical method used in this study. 
The deltamethrin content of nets that met the WHO criteria 
(cone and tunnel combined) was variable and ranged from 
0.208 g/kg to 0.818 g/kg (Table 5). 
 
Washing behaviour of local people 
In each country, two to five people were asked to wash a new 
100-denier PermaNet 2.0 one time.  People were not given 
soap, detergent or instructions but were asked to wash the nets 
as they would normally do so. Samples taken before and after 
washing were subjected to chemical assay to evaluate how 
much of the insecticide was washed off in each location.  A total 
of 19 nets were tested. 
 
The baseline deltamethrin concentration of unwashed nets was 
slightly higher than the target dose of 55 mg AI/m², but was 
within the acceptable range of 55 mg AI/m² + 25% for all nets 
with the exception of one net in Kenya. The loss of deltamethrin 
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after one wash was highly variable in all countries, ranging from 
1% to 44% (Table 6). 
 
Two additional three-year old PermaNet 2.0 (a white and a blue 
net) from Angola were sent to LIN/IRD for a wash resistance 
study. Previously, these nets were washed 0, 1, 5, 7, 8, 9 and 
10 times in Angola according to local traditions, i.e. hand-
washing with soap (in Angola, nets were washed with cold 
water using commercial bars or powdered soap. Nets were not 
rubbed against rocks or stones and were dried outside). Results 
show that both the knock-down effect and mortality were within 
WHO requirements in bioassay cones after 10 consecutive 
local washes for both white and blue nets.  
 
At the time of collection, household owners were asked how 
many times they had washed their net.  During physical 
inspection, the nets were assigned to one of four categories 
from clean to very dirty (Table 7).  Nets were washed 
infrequently in Angola, whereas in Ghana and Madagascar they 
were washed >15 times during the three-year period. Despite 
the frequent washing of nets in Madagascar, 69% of nets were 
scored as dirty to very dirty in year 3 (Table 7). 
 
Nets were classified into five different wash categories to 
evaluate the impact of washing on deltamethrin content. 
Significant differences between the classes were observed 
(ANOVA: p <0.001, R-squared = 0.157). The deltamethrin 
content decreased significantly with increasing numbers of 
washes (Table 8).  The mean deltamethrin content was 
0.617 g/kg on nets washed 1–5 times, 0.454 g/kg on nets 
washed 6–10 times, 0.419 g/kg on nets washed 11–15 times 
and 0.322 g/kg on nets washed >15 times.  
 
Physical nature of the nets (durability) 
Differences in the mean number of holes were observed per 
country and year. The nets from Ghana had the fewest holes, 
whereas the nets in Madagascar were heavily torn. Most holes 
were small, but 25% of the holes observed on two-year-old and 
three-year-old nets were larger than a person’s thumb.  
Approximately two-thirds or all holes were found on the lower 
half of the net (Table 9). The mean number of repairs per net 
ranged from 0.42 to 0.87. Few holes caused by burns were 
detected, with a maximum of 1.21 burns per net in Kenya.  The 
average number of holes ranged from 2.4 to 20.1 in one-year-
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old nets (66% of 75 denier nets), from 3.3 to 47.1 in two-year 
old nets (74% of 75 denier nets) and from 2.9 to 54.9 in three-
year-old nets (57% of 75 denier nets).   
 
 
3.3 Conclusions and recommendations 
 
PermaNet 2.0  is a deltamethrin-coated LN made of knitted 
poly-filament polyester fibres for which WHOPES has provided 
interim recommendations based on Phase I laboratory tests 
and small-scale field testing (experimental hut studies, 
WHOPES Phase II) (WHO, 2004). Full WHO recommendations 
require further evidence of the efficacy and durability as well as 
acceptability of the LN under routine household use over a 
period of three years.  
 
Testing and evaluation of public health pesticides by WHOPES 
are carried out at the request of industry. Time-limited (4-year) 
interim recommendations were introduced by WHOPES only in 
2006, giving WHO the possibility of withdrawing its interim 
recommendations in the absence of data or information needed 
to develop the full recommendations. 
 
Longitudinal randomized household trials to evaluate the 
efficacy, longevity and fabric integrity as well as the community 
acceptance of an LN are usually carried out in 2–3 countries 
over a period of three years. Published reports on performance 
of PermaNet 2.0 in operational settings are scarce. Only one 
published study followed the WHOPES guidelines, but with 
some modifications. Therefore, WHOPES supervised a multi-
country survey that provided additional data on bio-efficacy and 
durability in household conditions in different sites in six 
countries (Angola, Ghana, Kenya, Madagascar, Togo and 
Zambia).  
 
WHOPES guidelines recommend that at least 80% of nets 
tested after three years of routine household use meet the cut-
off criteria for either the WHO cone bioassay test or the tunnel 
test.   
 
In the longitudinal study in Uganda (Kilian et al., 2008), the 
PermaNet 2.0 showed excellent bio-efficacy after three years of 
routine household use.  Initial deltamethrin concentrations 
averaged 69.2 mg/m2, which is just above the acceptable range 
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of 55 mg/m2 + 25%. However, after three years of routine 
household use, the PermaNet 2.0 retained approximately 41% 
of the initial concentration of deltamethrin.  The average hole 
index increased linearly with time to an average index of 15 
(corresponding to 15 small holes or 5 large holes per net).  
Although the study did not fully conform to WHOPES guidelines 
for Phase III studies, it was concluded that three-year-old 
PermaNet 2.0 nets met the bio-efficacy criteria for Phase III 
evaluation of LNs in this study. 
 
In the WHOPES supervised multi-country survey, 85% of two-
year-old nets met the WHOPES criteria based on cone 
bioassay alone (>80% mortality or >95% knock-down). 
However, in two of the five countries, <80% of the PermaNet 
2.0 met the criteria for the cone test.   
 
After three years, only 57% of the nets met the criteria based on 
the cone test alone. In only one out of five countries did the 
PermaNet 2.0 meet these criteria after three years of routine 
household use.  The addition of tunnel test carried out on three-
year-old nets that failed the cone bioassay raised the proportion 
of nets meeting the WHOPES criteria to 80%.  However, even 
with the inclusion of the tunnel test, the PermaNet 2.0 fulfilled 
the WHOPES requirements in only three of the five countries. 
 
PermaNet 2.0 therefore has proven efficacy of three years 
when data are pooled from all countries. However the bio-
efficacy of three-year-old PermaNet 2.0 was marginal and there 
was high variability among countries. Furthermore, the 
performance may have been overestimated as the cross-
sectional study design may have under-sampled worn-out nets 
that may have been discarded by householders or where the 
age of the nets could not be verified due to washed-out or faded 
labels. 
 
The durability of the sampled nets as measured by inspection of 
the number and size of holes was highly variable between 
countries. The average number of holes per net was 12 after 
one year, increasing to 20 after two years. Some 25–30% of 
these holes were larger than a person's thumb. Two-thirds of 
the holes were situated on the lower half of the side panels. 
These percentages remained constant between years 2 and 3. 
The average number of openings along the seams was 0.4 per 
net. The durability of PermaNet 2.0 in this survey may have 
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been overestimated as the cross-sectional study design may 
have under-sampled worn-out nets.  
 
Noting the above, the meeting recommended: 
 
- that based on existing WHOPES guidelines, which 
are largely based on efficacy criteria, and noting the 
overall bio-efficacy of the PermaNet 2.0 in a multi-
country study, which is borderline, and the published 
literature, full recommendation is granted; 
 
- noting the borderline overall bio-efficacy and its high 
variability among countries, the poor fabric integrity 
in all study sites and the lack of criteria for durability, 
national programmes are strongly encouraged to 
monitor and evaluate the performance of the 
PermaNet 2.0 under local conditions when selecting 
the most suitable LN for their local setting.  
 
 
 
 
Note: WHO recommendations on the use of pesticides in 
public health are valid ONLY if linked to WHO 
specifications for their quality control.1 
                                                          
1 WHO specifications for pesticides used in public health are available 
at http://www.who.int/whopes/quality/newspecif/en/; accessed January 
2009. 
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4. REVIEW OF PERMANET  3.0 
 
PermaNet  3.0 is manufactured by Vestergaard Frandsen 
(Switzerland). The product is a combination of different LN 
technologies and is designed for the control of insecticide-
resistant mosquito populations. The roofing of PermaNet 3.0 
utilizes deltamethrin and a synergist, piperonyl butoxide, 
incorporated into monofilament polyethylene yarn of 100 denier 
(warp-knitted fabric, with weight of 40 + 15% g/m2) at the target 
dosage of 4.0 g AI/kg and 25 g AI/kg of netting material 
respectively. The side panels of PermaNet 3.0 are made of 
multi-filament polyester fibres, treated with deltamethrin in a 
resin coating (75 + 5% denier, warp-knitted fabric, atlas 
construction). The side netting has two parts: a strengthened 
lower part, so-called border (70 cm) by using 75 + 5% denier 
yarn (weight 40 + 10% g/m2) and a side panel made of 75 + 5% 
denier (weight of 30 + 10% g/m2). The target dosage of 
deltamethrin in the side panels is 2.8 g AI/kg of netting material, 
i.e. 115 mg AI/m2 of the border and 85 mg AI/m2 of the 
remaining of the side panels. 
 
 
4.1     Safety assessment 
 
The assessment of the risk to humans of washing and sleeping 
under the LN, provided by the manufacturer, was assessed by 
the Finnish Institute of Occupational Health (FIOH, 2007b) on 
behalf of the WHO Programme on Chemical Safety. The WHO 
Generic risk assessment model for insecticide treatment and 
subsequent use of mosquito nets 1  was used as a guiding 
document. The following assumptions were used by the 
proposer in drafting the assessment: 
 
- the hazards of the active components, deltamethrin and 
piperonyl butoxide, are adequately characterized in the 
most recent JMPR (FAO/WHO Joint Meeting on 
Pesticide Residues) assessments; 
                                                          
1 WHO (2004). A generic risk assessment model for insecticide 
treatment and subsequent use of mosquito nets. Geneva, World 
Health Organization (WHO/CDS/WHOPES/GCDPP/2004.6; available 
at http://whqlibdoc.who.int/hq/2004/WHO_PCS_04.1.pdf; accessed 
January 2009). 
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- for inhalation exposure, skin contact and hand-to-mouth 
transfer from sleeping under the treated nets, the WHO 
generic model and its default values are applied; 
- for direct mouth contact with the net, rather than the 
default assumptions of the generic model (which would 
indicate unacceptable exposures for newborns and 15-
kg infants), experimental data on the release of 
deltamethrin and piperonyl butoxide from the WHO 
washing procedure are assumed to reflect the 
availability for absorption of the AI in the net. Thus it is 
assumed that 4% (average of 10 successive washings) 
of the deltamethrin in the side net is translodgeable; for 
piperonyl butoxide (in the roof net), the equivalent 
average removal by washing is 1.8%; 
- for the assessment of the health risks from the washing 
of the treated nets, it is assumed that the net is washed 
in 10 litres of water, rather than the 2 litres often used in 
WHOPES assessments to date. However, it is assumed 
that the transfer of the AI to the washing liquid is similar 
to that of the default value of the generic model, i.e. 
30%, while the experimental data demonstrate that a 
more accurate figure would be 5–10%. As the exposure 
thus estimated represents <0.1% of the dermal 
acceptable exposure level, these minor differences have 
little impact on the risk estimates. 
 
FIOH concluded that: 
 
- the assessment of risk to health of the maintenance and 
use of PermaNet 3.0 by the manufacturer is generally 
performed in compliance with the WHO generic model; 
- when the generic model assumptions or default values 
are not adopted, they are replaced by data derived 
experimentally and are appropriately justified; 
- the conclusions of the safety assessment are justified;  
- when the instructions for use are followed, washing or 
sleeping under the LN does not pose undue risk to 
users (adults, children or newborns).  
 
 
4.2 Efficacy – background and supporting documents 
 
PermaNet 3.0 nets were evaluated in experimental huts in three 
field stations in central and west Africa: in Burkina Faso against 
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natural Kdr-resistant populations of An. gambiae s.s., in 
northern Cameroon against pyrethroid-resistant An. gambiae s.l. 
showing metabolic resistance and in Togo against free-flying 
pyrethroid-resistant Cx. quinquefasciatus.  
 
The west African-type experimental huts were used in these 
three settings.  Efficacy was evaluated in terms of blood-feeding 
inhibition, deterrence, induced exophily and mortality.  
 
In each locality, six trap huts were used and six treatment arms 
were tested, following the WHO guidelines.  Every week in 
Burkina Faso, northern Cameroon and Togo, after cleaning and 
ventilating the huts, treatment arms were rotated through the 
huts according to a Latin-square scheme. Sleepers were 
rotated randomly among huts each night of the study. Each net 
was deliberately holed with six holes (4 cm x 4 cm) to simulate 
a torn net. One additional net per treatment arm was used for 
chemical analyses and bioassays. Standard WHO procedures1 
for Phase II were used for washing the nets. For analysing the 
data of hut trials, rank tests for numeric data and logistic 
regression for proportional data were used. 
 
According to WHOPES supervised Phase I experiments 
(Duchon et al., 2008b), no regeneration time was required after 
washing, so that one day interval between successive washes 
was applied.   
 
The following arms were tested: (i) untreated net (same fabric 
as PermaNet  3.0); (ii) PermaNet  2.0  unwashed; (iii) PermaNet 
  2.0  washed 20 times; (iv) PermaNet 3.0   unwashed; (v) 
PermaNet 3.0   washed 20 times; and (vi) a conventionally 
treated net (CTN) of 75-denier polyester net treated with 
deltamethrin at 25 mg AI/m²  (0.83 g AI /kg) and washed to just 
before exhaustion, defined as the last wash that provides 
mortality >80% or knock-down >95%.   
 
The fully susceptible reference Kisumu strain of An. gambiae 
s.s. (2–5-day-old unfed  females) was used for the cone 
bioassays.  
                                                          
1 WHO (2005). Guidelines for laboratory and field testing of long-
lasting insecticidal mosquito nets. Geneva, World Health Organization 
(WHO/CDS/WHOPES/GCDPP/2005.11; available at 
http://www.who.int/whopes/guidelines/en/; accessed January 2009). 
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Kou Valley, Burkina Faso  
The efficacy of PermaNet 3.0 was investigated against natural 
Kdr-resistant populations of An. gambiae in experimental huts 
in the Kou Valley in Burkina Faso (Dabire et al., 2008b). The 
Kou Valley is a rice cultivation area surrounded by wooded 
savannah situated 30 km north of Bobo Dioulasso. Both 
molecular forms of An. gambiae s.s.  occur in sympatry but the 
S form increases in frequency (up to 85%) at the end of the 
rainy season (October–November). Knock-down (kdr) mutation 
occurs in both forms but at different frequencies (>90% in the S 
form and at around 20% for the M form).1,2   
 
All treated nets were fully effective before any washing, 
indicating the full bio-availability of deltamethrin regardless of 
treatment (knock-down and mortality 100%). The bio-efficacy of 
PermaNet 3.0 washed 20 times before and after the trial was 
very high (knock-down and mortality 100%) and satisfactory 
with PermaNet 2.0 (knock-down 100% and/or mortality >93%).  
The number of washes to just before exhaustion was two for 
the CTN (before field testing knock-down: 98%, mortality 90%).   
 
The AI content for unwashed PermaNet 2.0 (deltamethrin) and 
3.0 (deltamethrin + PBO) complied with the target doses (+ 
25%) (Tables 12–14). Overall deltamethrin retention for 
PermaNet 2.0 after 20 washes was 19%.  Overall AI retention 
for PermaNet 3.0 after 20 washes was 31% and 80% for 
deltamethrin on the side panels and roof respectively and 74% 
for PBO on the roof (Pigeon 2008c).       
       
The CTNs washed to just before exhaustion (two washes) 
contained 3.2 mg/m² (0.10 g/kg) deltamethrin, corresponding to 
a retention rate of about 15%. 
 
During a 6-week period (October–November 2007), 908 An. 
gambiae s.l. were collected in the control huts.  The unwashed 
PermaNet 2.0 and 3.0 induced a significant deterrent effect 
(64% and 49% respectively), while this was not significant for 
                                                          
1 Dabiré KR et al (2008). Dynamics of multiple insecticide resistance 
in the malaria vector Anopheles gambiae in a rice growing area in 
South-Western Burkina Faso. Malaria Journal, 2008, 7:188. 
2 Pennetier C et al (2008). Mixture for controlling insecticide-resistant 
malaria vectors. Emerging Infectious Disease, 14(11):1707–1714. 
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the other arms. Insecticide induced exophily was significant in 
all treated arms (42–72%).  
 
PermaNet 2.0 washed 20 times showed efficacy equal to CTNs 
washed to just before exhaustion, while PermaNet 3.0 washed 
20 times showed significantly higher efficacy in terms of blood-
feeding inhibition and mortality (Tables 10–11).  
 
Blood-feeding inhibition and mortality demonstrated the better 
efficacy of PermaNet 3.0 over PermaNet 2.0 when comparing 
unwashed nets or nets washed 20 times (Tables 10–11). No 
adverse effects were reported during the study. 
 
Pitoa, northern Cameroon 
The efficacy of PermaNet 3.0 against natural populations of An. 
gambiae was studied in experimental huts in northern 
Cameroon (Etang et al., 2008). The study site is located in a 
Soudanian area where An. gambiae s.l. (95% An. arabiensis, 
5% An. gambiae S form) and An. funestus are the major 
malaria vectors.  Insecticide susceptibility tests performed 
during the field trial showed that An. gambiae s.l. is moderately 
resistant to permethrin 0.75% (84% mortality) and deltamethrin 
0.05% (70% mortality) but not to DDT 4% (93% mortality). 
Increased oxidase and esterase activities have been observed 
in both An. gambiae and An. Arabiensis.1,2 The kdr mutation is 
very low (<5%) and only present in An. gambiae s.s. 
  
All treated nets were fully effective before any washing, 
indicating the full bio-availability of deltamethrin regardless of 
treatment (knock-down and mortality 100%). After 20 washes of 
PermaNet 3.0 and 2.0, KD and mortality remain above the 
threshold for both indicators (KD>95%, mortality >80%) and this 
before and after the trial. The number of washes to just before 
exhaustion was three for the CTN (before field testing KD: 92%, 
mortality 83%).   
 
                                                          
1 Etang J et al (2007). Spectrum of metabolic-based resistance to 
DDT and pyrethroids in Anopheles gambiae s.l. populations from 
Cameroon. Journal of Vector Ecology, 32 (1):123–133. 
2  Muller P et al (2008). Pyrethroid tolerance is associated with 
elevated expression of antioxidants and agricultural practice in 
Anopheles arabiensis sampled from an area of cotton fields in 
Northern Cameroon. Molecular Ecology, 17(4):1145–1155. 
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The AI content for unwashed PermaNet 3.0 (deltamethrin + 
PBO) complied with the target doses (+ 25%) (Tables 12-14). 
However for unwashed PermaNet 2.0, deltamethrin content 
(2.61 g/kg on average) was higher (+ 45%) than the target dose 
(1.8 g/kg). Overall deltamethrin retention for PermaNet 2.0 after 
20 washes was 25%.  Overall AI retention for PermaNet 3.0 
after 20 washes was 13% and 74% for deltamethrin on the side 
panels and roof respectively and 92% for PBO on the roof 
(Pigeon 2008f). The CTNs washed to just before exhaustion (3 
washes) contained 2.7 mg/m² (0.08 g/kg) deltamethrin, 
corresponding to a retention rate of about 10%. 
 
The results of experimental huts are reported for Anopheles 
without distinction of species (Etang et al., 2008).  
 
During a 6-week period (14 July to 23 August 2008), 401 
Anopheles (11.1 per night) were collected in the control huts.  
The PermaNet 2.0 washed 20 times and the CTN washed to 
before exhaustion did not reduce significantly the entry of 
Anopheles. Induced exophily (24–40%) increased significantly 
in all treated arms, but no difference was observed between 
these arms.  
 
The efficacy of PermaNet 2.0 and PermaNet 3.0 washed 20 
times on blood-feeding inhibition and mortality was equal to or 
higher than for a CTN washed to before exhaustion.  
 
PermaNet 3.0 induced a higher mortality than PermaNet 2.0, 
compared with both washed and unwashed nets. PermaNet 2.0 
induced a higher blood-feeding inhibition, although this was 
only significant for unwashed nets (Tables 10–11). No adverse 
effects were reported during the study. 
 
Akodésséwa, Lomé, Togo 
The efficacy of PermaNet 3.0 was investigated against wild 
populations of resistant Cx. quinquefasciatus in experimental 
huts in Togo (Ketoh et al., 2008). These huts are located in 
Akodésséwa, an urban district of Lomé where Cx. 
quinquefasciatus is abundant. A high level of resistance to DDT 
4% (mortality 7%), carbosulfan 0.4% (mortality 11%), 
permethrin 1% (mortality 10%), deltamethrin 0.05% (mortality 
6%) and, to a lesser extent, to organophosphates (chlorpyrifos-
methyl 0.4%; mortality 50%) was observed by WHO 
susceptibility tests performed in March 2008.  
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All treated nets were fully effective before any washing (knock-
down and mortality 100%), indicating the full bio-availability of 
deltamethrin regardless of treatment. The bioefficacy of 
PermaNet 3.0 washed 20 times before and after the trial was 
maximum (knock-down and mortality 100%). The mortality with 
PermaNet 2.0 washed 20 times was >80%, while knock-down 
was just below the cut off point (94%). The number of washes 
to just before exhaustion was three for the CTN (before field 
testing KD: 98%, mortality 86%).   
 
The AI content for unwashed PermaNet 2.0 (deltamethrin) and 
PermaNet 3.0 (deltamethrin + PBO) complied with the target 
doses (+ 25%) (Pigeon 2008e). Overall deltamethrin retention 
for PermaNet 2.0 after 20 washes was 16%.  Overall AI 
retention for PermaNet 3.0 after 20 washes was 23% and 85% 
for deltamethrin on the side panels and roof respectively and 
58% for PBO on the roof (Tables 12–14).    
    
The CTNs washed to just before exhaustion (three washes) 
contained 4.6 mg/m² (0.14 g/kg), deltamethrin corresponding  to 
a retention rate of about 19%.  
 
During a 6-week period corresponding to one full Latin square 
(18 February to 29 March 2008), 190 Cx. quinquefasciatus (5.3 
per night) were collected in the control arm. No deterrent effect 
was observed among the treated arms. Only LN arms induced 
a significant higher exophily than the control (22–50%). CTNs 
washed to just before exhaustion did not induce more blood-
feeding inhibition and mortality than the untreated nets, 
confirming the high level of pyrethroid resistance in Cx. 
quinquefasciatus.  Blood-feeding inhibition induced by both 
PermaNet (before and after washing) was higher compared 
with the CTN arm. Moreover, PermaNet 3.0 induced 
significantly higher blood-feeding inhibition (69%) than 
PermaNet 2.0 washed and unwashed. However, both 
PermaNet 2.0 and PermaNet 3.0 did not induce significantly 
higher mortality than the untreated nets. No adverse effects 
were reported during the study (Tables 10–11). 
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4.3 Efficacy – WHOPES supervised trials 
 
4.3.1 Laboratory studies 
 
The regeneration time, wash resistance and efficacy of 
PermaNet 3.0 provided by the manufacturer, were determined 
in laboratory (Phase I) studies according to WHOPES 
guidelines 1  against susceptible and pyrethroid-resistant An. 
gambiae s.s. (Duchon et al., 2008b). 
 
Chemical analyses were performed on net samples washed 0, 
1, 3, 5, 10, 15, 18, 20 and 25 times (Pigeon 2008d). Per wash 
regimen, 12 pieces from 4 nets taken on each part on the net 
(upper sides, lower border and roof) were analysed for 
determination of deltamethrin and piperonyl butoxide content. 
The analytical method used was based on CIPAC methods and 
involved extraction by heating under reflux with xylene and 
chromatographic determination by GC-FID using the internal 
standard calibration. 
 
Results of analysis for AI content and retention (wash curve) 
are presented in Figures 5–6. The between-net variation is 
expressed as the relative standard deviation (RSD) of the 
content found on the four pieces. Retention is calculated 
according to Annex 1 of the Report of the eleventh WHOPES 
Working Group Meeting, 2  assuming a free migration stage 
behaviour. 
 
The deltamethrin content in the sides (upper sides = 2.82 g/kg 
and strengthened border = 3.27 g/kg) and in the roof (4.66 g/kg) 
of the unwashed net complied with the target dose of 2.8 g/kg 
(± 25%) and 4 g/kg (± 25%) respectively. The piperonyl 
butoxide content (26.8 g/kg) in the roof of the unwashed net 
complied with the target dose of 25 g/kg (± 25%). For the 
                                                          
1 WHO (2005). Guidelines for laboratory and field testing of long-
lasting insecticidal mosquito nets. Geneva, World Health Organization 
(WHO/CDS/WHOPES/GCDPP/2005.11; available at: 
http://www.who.int/whopes/guidelines/en/; accessed January 2009). 
2 WHO (2008). Report of the eleventh WHOPES Working Group 
Meeting, WHO/HQ, Geneva 10–13 December 2007 
(WHO/HTM/NTD/WHOPES/2008.1; available at 
http://www.who.int/whopes/recommendations/wgm/en/; accessed 
January 2009). 
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unwashed net, the between-net RSD ranged from 3.4% to 5.6% 
for deltamethrin and was 3.8% for piperonyl butoxide. 
 
After 20 washes, for the sides of PermaNet 3.0, the average 
deltamethrin content was 1.30 g/kg (upper sides) and 1.57 g/kg 
(strengthened border). The overall deltamethrin retention after 
20 washes was 46% (upper sides) and 48% (strengthened 
border), corresponding to an average retention per wash of 
93% and 94% respectively. 
 
For the roof of PermaNet 3.0, the average AI content after 20 
washes was 4.17 g/kg for deltamethrin and 20.4 g/kg for 
piperonyl butoxide. The overall retention after 20 washes was 
90% for deltamethrin and 76% for piperonyl butoxide, 
corresponding to an average retention per wash of 99% and 
96% respectively. 
 
After three consecutive washes, the regeneration-time study 
carried out on susceptible An. gambiae Kisumu strain  showed  
that biological activity was maximal (knock-down 100%, 
mortality 100%) after 1 day for the three different parts (side, 
border, roof) of the net. This means that no regeneration time is 
needed after washing.   
 
Applying the same method on the roof material using the 
pyrethroid resistant An. gambiae strain (VKPR), 5 days were 
required to reach the plateau of knock-down. However, 
mortality sharply decreased after three consecutive washes 
(3%) and no regain of efficacy occurred after 15 days of storage 
at 30 °C.   
 
The wash-resistance study performed on fully susceptible 
mosquitoes showed that the efficacy of all parts of PermaNet 
fulfil the WHO requirements (mortality >80% and/or knock-down 
>95%) after 20 washes. 
 
However, despite a higher concentration of deltamethrin and 
the presence of PBO, the roof caused after 10 washes lower 
mortality (68%) on susceptible An. gambiae than the side 
panels (97%).  
 
Unwashed roof samples treated with PBO only (average 20.16 
mg/kg) have the capacity to kill 100% of the susceptible 
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mosquitoes. However, this killing effect was lost after washing 
(after 10 washes: 2% mortality, 3% knock-down).  
 
Roof samples were also bio-assayed using a kdr homozygote 
strain of An. gambiae s.s. (strain VKPER).  Despite the 
combination of a high dose of deltamethrin with the PBO, the 
efficacy of the roof samples against kdr-resistant mosquitoes 
was much lower than that recorded with fully susceptible 
vectors.  Mortality fell to 57% after 1 wash and knock-down of 
89% after five washes.  It should be noted that besides the 
target kdr resistance, no other biochemical resistance 
mechanism was described for the pyrethroid-resistant colony 
strain VKPER.   
 
 
4.3.2 Experimental hut studies  
 
Three field studies were implemented under WHOPES 
supervision: one in the Mekong Delta (Viet Nam) on a 
pyrethroid-resistant An. epiroticus population (Chinh et al., 
2008), one in Muheza district (United Republic of Tanzania) on 
a susceptible An. gambiae s.s. population (Tungu et al., 2008), 
and one in Malanville (Benin) on a partially pyrethroid-
susceptible An. gambiae s.l. population (Chabi et al., 2008). 
Experimental hut trials included also efficacy studies on wild 
Culex populations in Viet Nam and the United Republic of 
Tanzania. 
 
In Benin and the United Republic of Tanzania, the west and 
east African experimental huts respectively were used to 
evaluate the efficacy of PermaNet 3.0 in terms of blood-feeding 
inhibition, deterrence, induced exophily and mortality.1   
 
In Viet Nam, an adapted version of the west African 
experimental huts was used where mosquitoes can only escape 
outside to a single veranda trap. The entry side of the 
experimental huts faces a large brackish water swamp. Two 
entry slits (0.75 m) are foreseen at each side of the door and 
one large slit above the door over the entire width of the front 
                                                          
1 WHO (2005). Guidelines for laboratory and field testing of long-
lasting insecticidal mosquito nets. Geneva, World Health Organization 
(WHO/CDS/WHOPES/GCDPP/2005.11; available at: 
http://www.who.int/whopes/guidelines/en/; accessed January 2009). 
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side (3 m). These entry traps are covered by a curtain from 
05:00 to 18:00.  The back side of the house is foreseen with a 
full screened veranda. The houses are built on a concrete floor 
and have a wooden structure. The walls are covered outside 
with nipa leaves and inside with plastic hessian sheeting. The 
roof is of corrugated iron covered outside with palm tree leaves 
and inside with the plastic sheeting.  
 
Recapture rates for mosquitoes artificially released into these 
huts was 88%, indicating a satisfactorily low escape rate. The 
huts were free of scavengers (95% of the dead released 
mosquitoes were recaptured). Before the trial, no significant 
difference was observed between the entry rates of the different 
houses.   
 
In each locality, six trap huts were used and six treatment arms 
were tested, following the WHO guidelines.  Each week after 
cleaning and ventilating the huts, treatment arms were rotated 
through the huts according to a Latin square scheme. Sleepers 
were rotated randomly among huts each night of the study. 
Each net was deliberately holed with six holes (4 cm x 4 cm) to 
simulate a torn net. One additional net per treatment arm was 
used for chemical analyses and bioassays. Standard WHO 
procedures1 for Phase II were used for washing the nets. For 
analysing the data of hut trials rank tests (Benin, United 
Republic of Tanzania) or binomial negative regression (Viet 
Nam) for numeric data and logistic regression for proportional 
data were used. 
 
According to WHOPES supervised Phase I experiments 
(Duchon et al., 2008b) no regeneration time was required after 
washing, so that one day interval between successive washes 
was applied.   
 
In each locality, six trap huts were used and six treatment arms 
were tested, following the above-mentioned WHO guidelines. 
 
The following arms were tested: (i) untreated polyester net; (ii) 
PermaNet 2.0   unwashed; (iii) PermaNet 2.0   washed 20 times; 
                                                          
1  WHO (2005). Guidelines for laboratory and field testing of long-
lasting insecticidal mosquito nets. Geneva, World Health Organization 
(WHO/CDS/WHOPES/GCDPP/2005.11; available at: 
http://www.who.int/whopes/guidelines/en/; accessed January 2009). 
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(iv) PermaNet 3.0   unwashed; (v) PermaNet 3.0   washed 20 
times; and (vi) polyester net conventionally treated with 
deltamethrin at 25 mg/m², and washed just before exhaustion 
defined as the last wash that provide mortality >80% or knock-
down >95%.  Cone bioassays were carried out using 
pyrethroid-susceptible colony strains of An. gambiae (Kisumu 
strain) in Benin and the United Republic of Tanzania and of An. 
dirus s.s. in Viet Nam.  
 
Muheza District, United Republic of Tanzania 
In the study area, the wild An. gambiae s.s (S form) was fully 
susceptible and the Cx. quinquefasciatus population was highly 
resistant to deltamethrin (Tungu et al., 2008). Mortalities in 
WHO susceptibility tests were respectively 100% and 52% 
when exposed to deltamethrin discriminative dose of 0.05%. 
Earlier work on Culex in Meheza suggests the involvement of 
oxidases (Khayrandish & Wood 1993). 1  Recent work with 
synergists indicates additional involvement of esterases and a 
non-metabolic mechanisms in pyrethroid resistance (Rowland, 
unpublished).  
 
Before washing, all treatment arms showed 100% knock-down 
and mortality, indicating the full bio-availability of deltamethrin 
regardless of treatment. Bioassay tests on the 20 washed 
PermaNet 2.0. and 3.0 before and after the trial fulfilled the 
WHO requirements in terms of knock-down and mortality.  The 
number of washes to just before exhaustion was three for the 
CTN (before testing knock-down: 100%, mortality 100%).  At 
the end of the trial, knock-down and mortality decreased to 88% 
and 90% respectively. 
   
The AI content for unwashed PermaNet 2.0 (deltamethrin) and  
PermaNet 3.0 (deltamethrin + PBO) complied with the target 
doses (+ 25%) (Tables 12–14). Overall deltamethrin retention 
for PermaNet 2.0 after 20 washes was 32%.  Overall AI 
retention for PermaNet 3.0 after 20 washes was 47% and 80% 
for deltamethrin on the side panels and roof respectively and 
80% for PBO on the roof.   The conventionally treated nets 
                                                          
1 Khayandish A, Wood RJ (1993) A multiple basis for insecticide 
resistance in a strain of Culex quinquefasciatus from Muheza 
Tanzania, studied as resistance declined. Bulletin of 
Entomological Research, 83:75–86. 
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washed to just before exhaustion (three washes) contained 
after the trial 3.8 mg/m² (0.11 g/kg) deltamethrin (Pigeon 2008g).   
 
During a 9-week period (7 July to 4 October 2008), 723 An. 
gambiae (13.4 per night) and 81 Culex  (1.5 per night) were 
collected in the control huts.  No significant deterrent effect was 
induced by any of the treatments for either species.  
 
For Culex, induced exophily (58–74%) was significant for all 
treatment arms. For An. gambiae owing to the high natural 
exiting rate (86%) no significant induced exophily was observed 
in the treated arms except for the CTN (7%).    
 
The mortality of susceptible wild An. gambiae with unwashed 
PermaNet 2.0 (96%) and unwashed PermaNet 3.0 (96%), or 
with these LN both washed 20 times (87% or 95% respectively) 
exceeded that of the CTN washed to just before exhaustion 
(73%)(Table 11). However PermaNet 2.0 and PermaNet 3.0 
washed 20 times did not induce significantly higher blood-
feeding inhibition than a CTN washed to just before exhaustion 
(Table 10).  
 
For Cx. quinquefasciatus, blood-feeding inhibition was very high 
(>70%) in all treatment arms compared to control and reached 
100% with both PermaNets washed 20 times. Both PermaNet 
2.0 and PermaNet 3.0 performed equal to or better than the 
CTN just before exhaustion in terms of blood-feeding inhibition 
and mortality. Mortality was higher with PermaNet 3.0 (51%) 
than with PermaNet 2.0 (36%) when unwashed but this 
difference was no longer evident after 20 washes (about 35% 
mortality) (Table 11).  
 
Additional cone bioassays tests and tunnel tests using also a 
pyrethroid-resistant Cx. quinquefasciatus strain (Masimbani  
strain resistant to permethrin) produced trends consistent with 
the experimental hut trial. A higher mortality rate was observed 
with the roof panel over the side panel against pyrethroid 
resistant Culex (Masimbani strain) but this effect was lost after 
washing.  
 
Bac Lieu, Viet Nam 
In this  study area, An. epiroticus (formally An. sundaicus) is the 
dominant mosquito species (Chinh et al., 2008).   
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An. epiroticus was found to be resistant to permethrin, 
deltamethrin, alpha-cypermethrin and lambda-cyhalothrin but 
fully susceptible to DDT1. No kdr mutation has been observed 
for this species and biochemical assays suggest an esterase 
mediated pyrethroid detoxification (Verhaeghen et al., 2008, 
unpublished report). Tests performed in 2005 shows also a full 
susceptibility against propoxur and malathion.  The wild 
population was retested in October 2008 and resistance to 
deltamethrin was reconfirmed (deltamethrin 0.05%: mortality 
75%). The Culex population has not been tested for insecticide 
susceptibility.   
 
Before any wash, all treated nets were effective (knock-down 
>95% and mortality 100%) indicating the bio-availability of 
deltamethrin regardless to the treatments. Resistance to 20 
washes of both PermaNet 2.0. and 3.0 was within the WHO 
requirements (knock-down >95% and/or mortality >100%) 
before and after the trial.   
 
The number of washes to just before exhaustion was five for 
the CTN (knock-down 94%, mortality 90%).  At the end of the 
trial, knock-down and mortality decreased to 38% and 24% 
respectively. 
 
The AI content for unwashed PermaNet 3.0 (deltamethrin + 
PBO) and PermaNet 2.0 (deltamethrin) complied with the target 
doses (± 25%) (Pigeon 2009b).  However for one unwashed net 
of PermaNet 3.0, the average deltamethrin content in the sides 
panel (2.05 g/kg) was just below the lower limit (2.1 g/kg) of the 
target dose.  For this same unwashed PermaNet 3.0, the within-
side RSD was very high.  The overall AI retention for PermaNet 
3.0 after 20 washes was 55% and 100% for deltamethrin on the 
side panels and roof respectively and 72% for piperonyl 
butoxide on the roof.  The overall deltamethrin retention for 
PermaNet 2.0 after 20 washes was 50%. 
 
The within-side RSD of deltamethrin content was 4.4–10.4% 
and 1.6% for the side panels and roof respectively in one 
unwashed PermaNet 3.0, and 29.8–42.4% and 1.1% for the 
side panels and roof respectively for another unwashed 
PermaNet 3.0.  The within-side and roof RSD of deltamethrin 
                                                          
1 Van Bortel W et al. (2008). The insecticide resistance status of malaria 
vectors in the Mekong region. Malaria Journal, 7:102. 
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content in unwashed PermaNet 2.0 was 0.7-6.2%.  The within-
net RSD of deltamethrin content in the side panels was 1.9-
12.0% and 2.1-4.3% respectively for unwashed PermaNet 3.0 
and 2.0. 
 
The conventionally treated net washed to just before exhaustion 
(5 washes) contained 5.5 mg/m² (0.17 g/kg) deltamethrin 
corresponding to a retention rate of 22%. 
   
During a 6-week period (22 September to 2 November 2008), 
4,114 An. epiroticus (114.3 per night) and 1,141 Culex (31.7 per 
night) were collected in the control huts.   
 
For An. epiroticus only, PermaNet 3.0 washed 20 times induced 
a significant deterrent effect (35%) while only PermaNet 2.0 
unwashed deterred Culex mosquitoes (50%).  All treatments 
increased the exophily of Culex where no clear trend was 
observed with An. epiroticus.  
 
All PermaNet arms are performing almost equally to or slightly 
better than CTNs washed to just before exhaustion, and we can 
conclude that PermaNet 3.0 fulfils the criteria of an LN (Tables 
10–11). 
 
For Anopheles epiroticus, PermaNet 3.0 washed 20 times did 
not induce a significantly higher blood-feeding inhibition than 
PermaNet 2.0 washed 20 times (73% versus 68%) (Table 10). 
The significant difference in proportion of blood fed mosquitoes 
between PermaNet 2.0 and PermaNet 3.0 unwashed was 
biologically not relevant (6.6% and 4.6% respectively). 
 
A high Anopheles mortality was observed in the control hut 
(34%) which was mainly attributable to the unfed females 
(mortality of 42%) while the mortality of fed females was around 
10%.  The mortality with PermaNet 2.0 and PermaNet 3.0, 
unwashed or washed 20 times, exceeded that of the CTN 
washed before exhaustion (70%). The overall mortality with 
PermaNet 3.0 washed 20 times was significantly higher  than 
with PermaNet 2.0 washed 20 times (92% and 82% 
respectively), but this difference disappears when considering 
only blood-fed females (94% and 92% respectively) (Table 11).  
 
The blood-feeding rate in Culex was significantly reduced in the 
PermaNet treated arms (1.6–4.8%) compared with the 
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untreated nets (15%) and CTNs washed to just before 
exhaustion (9%) (Table 10). For Culex mosquitoes, only 
immediate mortality (1.2% in the control arm) was observed. 
The mortality for Culex in all treated arms was rather low 
(<20%).  The mortality was not different between the two 
PermaNet washed 20 times and the CTN washed to just before 
exhaustion (about 7%) (Table 11).  
 
Malanville, Benin 
In this irrigated area An. gambiae s.l. is the main malaria vector 
with 95% An. gambiae s.s. (M form) and 5% An. arabiensis. 
Both species when exposed to discriminative doses are almost 
susceptible to permethrin 0.75% (mortality 93%), deltamethrin 
0.05% (mortality 85%) and lamda-cyhalothrin 0.05% (mortality 
92%).  
 
Before any washing, all treated nets were fully effective 
indicating the full bio-availability of deltamethrin regardless of 
the treatments (knock-down and mortality 100%) (Chabi et al., 
2008).  Resistance to 20 washes of both PermaNet 2.0. and 3.0 
met the WHO requirements before and after the trial.  The 
number of washes to just before exhaustion was three for the 
CTN (before field testing knock-down: 95%, mortality 82%).  At 
the end of the trial, knock-down and mortality were 85% and 
82% respectively. 
The AI content for unwashed PermaNet 3.0 (deltamethrin + 
PBO) and PermaNet 2.0 (deltamethrin) complied with the target 
doses (± 25%) (Pigeon 2009c).  However for one unwashed net 
of PermaNet 2.0, the average deltamethrin content in the sides 
panel and roof was higher (2.41 and 2.87 g/kg respectively) 
than the upper limit of the target dose (2.25 g/kg). 
The overall AI retention for PermaNet 3.0 after 20 washes was 
26% and 91% for deltamethrin on the side panels and roof 
respectively and 70% for piperonyl butoxide on the roof.  The 
overall deltamethrin retention for PermaNet 2.0 after 20 washes 
was 23%.   
The within-net RSD of deltamethrin content in the side panels is 
4.2-7.3% and 1.1-7.3% for unwashed PermaNet 3.0 and 2.0 
respectively. 
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The conventionally treated net washed to just before exhaustion 
contains 2.0 mg/m² (0.06 g/kg) deltamethrin corresponding to a 
retention rate of 11%. 
 
During a 12-week period (21 July to 11 October, 72 nights) 
corresponding to two full Latin square schemes, 285 An. 
gambiae s.l.  (3.9 per night) were collected in the control huts.  
No deterrent effect was observed with neither of the treatments, 
however all treatments induced significantly higher exophily 
(23–57%). 
 
This study demonstrated that the global efficacy (blood-feeding 
inhibition and mortality) of 20 times washed PermaNet 2.0 and 
3.0 was equal to or higher than that of a CTN washed to just 
before exhaustion (Tables 10–11).  
 
The blood-feeding inhibition of PermaNet 3.0 washed 20 times 
was significantly lower (66%) than for PermaNet 2.0 unwashed 
or washed 20 times (respectively 90% and 84%). For 20 times 
washed nets, mortality (69%) was similar between PermaNet 
3.0 and 2.0.   
 
 
4.4 Conclusions and recommendations 
 
PermaNet  3.0, an LN manufactured by Vestergaard Frandsen 
(Switzerland), is intended to control pyrethroid-resistant 
mosquitoes. The net is a combination of two fabrics: the roof 
with a knitted 100 denier monofilament polyethylene fibre 
blended with deltamethrin 4 g/kg + piperonyl butoxide (PBO) 25 
g/kg  and side panels with knitted multifilament polyester (75 
denier) fibres coated with  deltamethrin at the target dose of 2.8 
g/kg. The fabric of the lower part of the side panels is more 
densely knitted (40+ 10% g/m²) than the upper part (30+ 10% 
g/m²).  
 
The WHO assessment of the manufacturer’s compliance with 
the assessment of exposure to and risks of washing and 
sleeping under a PermaNet 3.0 was in line with the WHO 
generic risk assessment model and their conclusions were 
accepted.   
 
Laboratory studies on fully susceptible mosquitoes revealed 
that PermaNet 3 meets WHOPES Phase I requirements 
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(mortality >80% or knock-down >95%) after 20 washes for each 
of the three parts of the net (side, border, roof). No regeneration 
time is needed after washing any of the three different parts of 
the net. Despite a higher concentration of deltamethrin and the 
presence of PBO, the roof after washing induces lower 
mortalities than the side panels.  
 
The unwashed roof panel is fully effective against a homozygte 
kdr resistant strain of An.gambiae. However biological activity 
(mortality and knock-down) declines after only a few washes.   
 
Chemical analyses of unwashed PermaNet 3.0 in Phase I 
testing showed a compliance of the AI and synergist content 
with the target doses and a good between-net homogeneity. 
The deltamethrin retention after washing was much higher in 
the roof than in the sides.  There was no difference observed 
between upper and lower part of the sides (Figures 5 & 6). The 
PBO retention after washing was slightly lower than that of the 
deltamethrin in the roof. PBO retention increases with the 
number of washes and after 15 washes no release of PBO 
seems to occur.   
 
In all the Phase II trials excepted for some samples, the AI and 
synergist content in unwashed PermaNet 3.0 complied with the 
target doses (Tables 12-14),  PermaNet 3.0 showed also a 
good within-net homogeneity.  The deltamethrin and PBO 
retention in the roof was around 2.5 times higher than that of 
deltamethrin in the sides panels. 
 
Field studies demonstrated a better or equal impact of 
PermaNet  3.0 LNs washed 20 times on mortality and blood-
feeding inhibition of prominent malaria vectors compared with 
that of the conventionally treated polyester nets (25  mg/m² AI) 
washed until just before exhaustion. This confirms that the 
PermaNet  3.0 fulfils the WHOPES efficacy criteria of Phase II 
studies for LN.   
 
In most studies, an unwashed PermaNet 3.0 performed better 
than an unwashed PermaNet 2.0 on Anopheles populations.  
After washing 20 times, PermaNet 3.0 performed better for both 
mortality and blood-feeding inhibition only in Burkina Faso 
compared to a PermaNet 2.0 but still 50% of the resistant 
anopheles survived after the exposure to PermaNet 3.0. In the 
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other four sites (Viet Nam, Benin, Cameroon, United Republic 
of Tanzania) little or no additional benefit over PermaNet 2.0 
was observed (Tables 10 and 11).   
 
PermaNet 3.0 washed or unwashed did not kill more resistant 
Culex mosquitoes than PermaNet 2.0 and the mortality rates 
were low. In Togo, blood-feeding inhibition with PermaNet 3.0 
(washed and unwashed) was higher than that induced by 
Permanent 2.0 (Table 11). 
  
Considering the safety, efficacy and wash-resistance of 
PermaNet  3.0  in laboratory studies and small-scale field 
studies, its is recommended:  
 
- that a time limited interim recommendation be given for the 
use of PermaNet 3.0 in the control and prevention of 
malaria; 
 
- that WHOPES coordinates large-scale studies (WHOPES 
Phase III studies) of PermaNet 3.0 to confirm its long-lasting 
efficacy, fabric integrity and community acceptability as a 
requirement for developing full recommendations on the use 
of the product. 
 
Following a review of the available evidence, the meeting 
concluded 
 
- that the PermaNet 3.0 cannot be considered as a 
tool to control mosquito populations resistant to 
pyrethroids or to prevent the spread of pyrethroid 
resistance.  However, the meeting commended the 
manufacturer for its initiative in developing tools to 
control pyrethroid-resistant mosquitoes and 
encourages it to conduct further research and 
development in this area. 
 
 
Note: WHO recommendations on the use of pesticides in 
public health are valid ONLY if linked to WHO 
specifications for their quality control.1 
                                                          
1 WHO specifications for pesticides used in public health are available 
at http://www.who.int/whopes/quality/newspecif/en/; accessed January 
2009. 
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5. REVIEW OF PERMANET  2.5 
 
PermaNet  2.5 (= PermaNet  2.0 Extra) is a deltamethrin-
coated) LN manufactured by Vestergaard Frandsen 
(Switzerland). The net is made of warp-knitted multi-filament 
polyester fibres. The side netting has two parts: a strengthened 
lower panel, the so-called border (70 cm) made of 75 + 5% 
denier yarn (weight 40 + 10% g/m2) and the upper side panel 
made of 75 + 5% denier (weight of 30 + 10% g/m2). The target 
dosage of deltamethrin in the side panels is 2.8 g AI/kg of 
netting material, i.e. 115 mg AI/m2 of the border and 85 mg 
AI/m2 of the remaining of the side panels and the roof. 
 
 
5.1     Safety assessment  
 
Noting the specifications of PermaNet 2.5 and that netting used 
in making the product is of the same specifications as that of 
the side panels of PermaNet 3.0, the WHO risk assessment of 
the latter has been used and no separate assessment carried 
out (see sections 4 and 4.1). It has been concluded that when 
the instructions for use are followed, washing or sleeping under 
the LN do not pose undue risk to the users (adults, children or 
newborns).  
 
 
5.2 Efficacy – WHOPES supervised trials 
 
5.2.1 Laboratory studies 
 
The regeneration time, wash resistance and efficacy of netting 
used in making PermaNet 2.5, were determined in laboratory 
(Phase I) according to WHOPES guidelines1against susceptible 
An. gambiae s.s. (Duchon et al., 2008b) and as part of 
WHOPES testing and evaluation of PermaNet 3.0. 
 
Chemical analyses were performed (Pigeon 2008d) on net 
samples washed 0, 1, 3, 5, 10, 15, 18, 20 and 25 times. For 
                                                          
1 WHO (2005). Guidelines for laboratory and field testing of long-
lasting insecticidal mosquito nets. Geneva, World Health Organization 
(WHO/CDS/WHOPES/GCDPP/2005.11; available at: 
http://www.who.int/whopes/guidelines/en/; accessed January 2009). 
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each wash interval, 8 pieces from 4 nets taken from upper side 
panel and lower border panel were analysed for determination 
of deltamethrin content. The analytical method used was based 
on CIPAC method and involved extraction by heating under 
reflux with xylene and chromatographic determination by GC-
FID using the internal standard calibration. 
 
Results of analysis for AI content and retention (wash curve) 
are presented in Figure 5. The between-net variation is 
expressed as the RSD of the content found on the 4 pieces. 
Retention is calculated according to the Annex 1 of the Report 
of the eleventh WHOPES Working Group Meeting, assuming a 
free migration stage behaviour. 
 
The deltamethrin content in the side panel (upper section = 2.82 
g/kg and lower strengthened border = 3.27 g/kg) of the 
unwashed net complied with the target dose of 2.8 g/kg (± 25%).  
The between-net variation as expressed by RSD ranged from 
3.4% to 5.6%. 
 
After 20 washes, the average deltamethrin content was 1.30 
g/kg (upper side panel) and 1.57 g/kg (lower strengthened 
border). The overall deltamethrin retention after 20 washes was 
46% (upper side panel) and 48% (strengthened border) 
corresponding to an average retention per wash of 93% and 
94% respectively. 
 
The regeneration time after 3 consecutive washes as 
determined by cone bioassay using susceptible An. gambiae 
Kisumu strain  showed  that bio-efficacy was fully restored after 
1 day (i.e. knock-down: 100%, mortality 100%). This means that 
no regeneration time is needed after washing.   
 
The wash resistance study performed on fully susceptible 
mosquitoes showed that the efficacy of the two parts of 
PermaNet fulfil the WHO requirements (mortality >80% and/or 
knock-down >95%) after 20 washes. 
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5.2.2 Experimental hut studies  
 
The experimental hut trials were set out to demonstrate whether 
(i) PermaNet 2.5 meets the criterion of an LN by comparison 
with conventionally treated net (CTN) washed to just before 
exhaustion and (ii) whether PermaNet 2.5 shows superiority or 
equivalence to its predecessor PermaNet 2.0.  
 
Malanville, North Benin  
PermaNet 2.5 LNs were evaluated in experimental huts located 
in irrigated rice field area, Malanville North Benin (Chabi et al. 
2008).  This evaluation was built into a larger study of 
PermaNet 3.0 conducted at the same time. However, only the 
treatment arms pertinent to the evaluation of PermaNet 2.5 are 
described in this section. An. gambiae s.l. is the main malaria 
vector in Malanville with 95% An. gambiae s.s. (M form) and 5% 
An. arabiensis. Both species when exposed to discriminative 
doses are susceptible to permethrin (93% mortality), 
deltamethrin (85% mortality) and lamda-cyhalothrin (92.2% 
mortality). The west African experimental huts were used in this 
setting and the procedure followed the above-mentioned 
WHOPES Guidelines. Efficacy was evaluated in terms of blood-
feeding inhibition, deterrence, induced exophily and mortality.  
 
Six treatment arms were tested: (i) untreated net (same fabric 
as PermaNet 2.5); (ii) PermaNet 2.0  unwashed; (iii) PermaNet  
2.0  washed 20 times; (iv) PermaNet 2.5  washed 20 times; (v) 
Polyester net conventionally treated  with deltamethrin at 25 
mg/m²  AI; and (vi)  Polyester net conventionally treated with 
deltamethrin at 25 mg/m²  AI and washed 3 times i.e., to just 
before exhaustion using cone tests with An. gambiae Kisumu 
strain. An unwashed PermaNet 2.5 treatment arm could not be 
included in this trial owing to a shortage of huts. However, its 
absence did not affect the conclusions of the study. 
 
Six nets per treatment arm were tested during each weekly 
rotation, one net on each of the six nights. On night 7, the huts 
were cleaned and ventilated. Two complete Latin square 
rotations were necessary to obtain sufficient numbers of 
mosquitoes for statistical power.  
 
The fully susceptible Kisumu strain of An. gambiae was used 
for the cone bioassays. Prior to washing treated nets in each 
treatment group gave 100% KD and 100% mortality. After field 
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testing, the 20 times washed PermaNet  2.5 induced 100% KD 
and 100% mortality. The PermaNet 2.0 washed 20 times gave 
97% mortality and the conventional treated net washed just 
before exhaustion gave 89% mortality.  
 
Overall, 285 An.gambiae s.l.  (3.9 per night) were collected in 
the control huts during the trial period (21 July to 11 October).  
No deterrent effect was observed with any of the treatments. All 
insecticide treatments induced significantly higher exophily (33 
to 50%). 
 
This study demonstrated that blood-feeding inhibition and 
mortality of 20 times washed PermaNet 2.0 (84% and 71% 
respectively) and PermaNet  2.5 (91% and 78%) were not 
significantly different from one another. Each was significantly 
higher than that of a conventionally deltamethrin treated net 
washed to just before exhaustion (72% BFI and 61% mortality).  
 
After Phase II testing, the PermaNet 2.5 washed 20 times still 
contained 1.38 g/kg and 0.72 g/kg deltamethrin in the side 
panels and roof respectively, corresponding to a retention rate 
of 49% and 26% respectively (Pigeon 2009c). 
 
Kilimanjaro district, United Republic of Tanzania   
PermaNet 2.5 was tested in the Lower Moshi rice irrigation 
scheme (Kilimanjaro district, United Republic of Tanzania) 
where An. arabiensis is a dominant mosquito species from 
October to November (Oxborough et al., 2008). The east 
African experimental hut type was used.1  
 
The following arms were tested: (i) untreated net;  (ii) PermaNet 
2.0   unwashed; (iii) PermaNet 2.0   washed 20 times; (iv) 
PermaNet 2.5   unwashed; (v) PermaNet 2.5   washed 20 times; 
and (vi) polyester net conventionally treated  with deltamethrin 
at 25 mg/m²  and washed three times, i.e. to just before 
exhaustion in cone tests using the pyrethroid susceptible An. 
gambiae Kisumu strain.  
 
                                                          
1 WHO (2005). Guidelines for laboratory and field testing of long-
lasting insecticidal mosquito nets. Geneva, World Health Organization 
(WHO/CDS/WHOPES/GCDPP/2005.11; available at: 
http://www.who.int/whopes/guidelines/en/; accessed January 2009). 
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Each treatment was rotated through each of the six huts. Owing 
to time constraints each rotation took only 3 days and the entire 
trial was completed in 24 days. Three nets per treatment arm 
were tested during each rotation, one net on each of the 3 
nights. On night 4, the huts were cleaned and ventilated. Only 
one Latin square rotation was necessary to obtain sufficient 
numbers of mosquitoes for statistical analysis owing to the high 
densities of An. arabiensis present during the trial period.  
 
The fully susceptible Kisumu strain of An. gambiae was used 
for cone bioassays. Prior to washing all treated nets gave 100% 
KD and 100% mortality regardless of treatment. After field 
testing, the PermaNet 2.5 washed 20 times induced 95% KD 
and 81% mortality. The PermaNet 2.0 washed 20 times gave 
97% knock-down and 81% mortality. The conventional treated 
net washed just before exhaustion gave 59% knock-down and 
33% mortality. 
Not considering an outlier value, the deltamethrin content in 
unwashed PermaNet 2.5 and 2.0 complied with the target 
doses (± 25%) (Pigeon 2009d).  The overall deltamethrin 
retention in PermaNet 2.5 and 2.0 after 20 washes was 27% 
and 30% respectively. 
The within-net RSD of deltamethrin content in unwashed 
PermaNet 2.5 and 2.0 was 5.4-14.5% and 5.8-8.5% 
respectively. 
The conventionally treated net washed to just before exhaustion 
contained 2.7 mg/m² (0.09 g/kg) deltamethrin corresponding to 
a retention rate of 12%. 
 
During the collecting period (20 October to 12 November 2008), 
197 An. arabiensis (11 per night) were collected in the control 
huts.  No deterrent effect was observed with any of the 
treatments. An. arabiensis is inherently exophilic and 75% of 
mosquitoes were collected from the veranda traps in the 
mornings. Insecticide induced exophily was observed for all 
types of insecticide treated nets tested.  
 
The blood-feeding rate with the untreated net was 43%. A slight 
but significant reduction in blood-feeding was observed with all 
types of treated net. Blood-feeding inhibition of the 20 times 
washed PermaNet 2.0 (17%) and PermaNet  2.5 (21%) were 
not significantly different from one another or from a 
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conventionally deltamethrin treated net washed to just before 
exhaustion (24%). Mortality with the unwashed PermanNet 2.5 
(50%) did not differ significantly from that of the unwashed 
PermaNet 2.0 (46%). Mortality was significantly lower in the 
PermaNet washed  20 times, but again there was no significant 
difference between PermaNet 2.5 (35% mortality) and 
PermaNet 2.0 (36%). Each was significantly higher than that of 
a conventionally deltamethrin treated net washed to just before 
exhaustion (23% mortality). The relative low mortality as 
compared to trials with An. gambiae can be explained by the 
natural behavioural trait of An. arabiensis towards zoophily and 
exophily.  
 
 
5.3 Conclusions and recommendations 
 
PermaNet  2.5 (= PermaNet  2.0 Extra) is a deltamethrin-
coated LN manufactured by Vestergaard Frandsen 
(Switzerland). The net is made of warp-knitted multi-filament 
polyester fibres. The side netting has two parts: a lower, so-
called border (70 cm) made of 75 + 5% denier yarn with 
strengthened durability (weight 40 + 10% g/m2) and the upper 
side panel made of 75 + 5% denier (weight of 30 + 10% g/m2). 
The target dosage of deltamethrin in the side panels is 2.8 g 
AI/kg of netting material, i.e. 115 mg AI/m2 on the border and 85 
mg AI/m2 on the upper side panels. 
 
The WHO assessment of the compliance of the manufacturer’s 
assessment of exposure to and risks of washing and sleeping 
under a PermaNet 2.5 LN was generally in line with the WHO 
generic risk assessment model. When the generic model 
assumptions or default values were not adopted, they were 
replaced by data derived experimentally and appropriately 
justified. The assessment concluded that washing or sleeping 
under the LN do not pose undue risk to adults, children or 
newborns.  
 
The deltamethrin content in the side panel (upper section = 2.82 
g/kg; lower strengthened border = 3.27 g/kg) of the unwashed 
net was consistent with the target dose of 2.8 g/kg (± 25%). The 
between-net variation as expressed by RSD ranged from 3.4% 
to 5.6%. After 20 washes, the average deltamethrin content 
was 1.30 g/kg (upper side panel) and 1.57 g/kg (lower 
strengthened border). The overall deltamethrin retention after 
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20 washes was 46% (upper side panel) and 48% (strengthened 
border), corresponding to an average retention per wash of 
93% and 94% respectively. 
 
The regeneration time after three consecutive washes as 
determined by cone bioassay using susceptible An.gambiae 
Kisumu strain  showed that bioefficacy was fully restored after 1 
day (i.e. KD: 100%, mortality 100%). This means that no 
regeneration time is needed after washing. The wash 
resistance study performed on fully susceptible mosquitoes 
showed that the efficacy of the two parts of PermaNet 2.5  fulfil 
the WHO requirements (mortality >80% and/or knock-down 
>95%) after 20 washes. 
 
The experimental hut trials in Benin and the United Republic of 
Tanzania set out to demonstrate whether (i) PermaNet 2.5 
meets the criterion of a long lasing insecticidal net by 
comparison with CTN washed to just before exhaustion and (ii) 
whether PermaNet 2.5 shows superiority or equivalence to its 
predecessor PermaNet 2.0.  
 
Both experimental hut studies demonstrated that the PermaNet 
2.5 washed 20 times performed equal to or better than a 
conventionally treated net washed until exhaustion in terms of 
blood-feeding inhibition and mortality.  However, there was no 
difference in efficacy of a PermaNet 2.5 washed 20 times 
compared to a PermaNet 2.0 washed 20 times in terms of 
blood-feeding inhibition and mortality.  A loss of efficacy was 
observed in a PermaNet 2.5 over 20 washes.  
 
In the Phase II trials, deltamethrin content in unwashed 
PermaNet 2.5 complied with the target doses and was uniformly 
distributed within the net.  
 
Given the safety, efficacy and resistance to washing of the 
PermaNet 2.5 in laboratory studies and small-scale field studies, 
it is recommended: 
 
  that a time-limited interim recommendation be given for 
the use of PermaNet 2.5 in the prevention and control of 
malaria; 
 
  that WHOPES coordinates large-scale field studies 
(WHOPES Phase III studies) of  PermaNet 2.5 to 
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confirm its long-lasting efficacy and fabric integrity, as 
well as community acceptability, as a requirement for 
developing full recommendations on the use of the 
product.  
 
 
 
Note: WHO recommendations on the use of pesticides in 
public health are valid ONLY if linked to WHO 
specifications for their quality control.
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6. REVIEW OF LAMBDA-CYHALOTHRIN LN OF 
SYNGENTA 
 
The lambda-cyhalothrin LN of Syngenta, Switzerland (= ICON  
MAXX-Net) is a factory-produced polyester LN treated with the 
slow-release capsule suspension of lambda-cyhalothrin, ICON  
10 CS. The insecticide is coated on polyester netting at the 
target dose of 50 mg AI/m2 using a polymer as a binder. 
Lambda-cyhalothrin CS has been previously evaluated by 
WHOPES and recommended for treatment of mosquito nets.1 
 
The manufacturer has disclosed the nature of the binder used 
in coating the LN and has confirmed that it is the same as the 
binder used in making ICON MAXX mosquito net treatment kit2 
already subject to the WHO safety assessment. 
 
 
6.1 Safety assessment 
 
The assessment of the risk to humans of washing and sleeping 
under the LN, provided by the manufacturer was assessed by 
FIOH (FIOH, 2007a) on behalf of the WHO Programme on 
Chemical Safety. The WHO Generic risk assessment model for 
insecticide treatment and subsequent use of mosquito nets3 
was used as a guiding document. 
 
The following assumptions/methodologies were used by the 
proposer in drafting the assessment: 
 
                                                          
1 Report of the fourth WHOPES Working Group Meeting, WHO/HQ, 
Geneva, 4-5 December 2000. Geneva, World Health Organization, 
2001 (WHO/CDS/WHOPES/2001.4; available at: 
http://whqlibdoc.who.int/hq/2001/WHO_CDS_WHOPES_2001.4.pdf; 
accessed January 2009). 
2 Report of the eleventh WHOPES Working Group Meeting, WHO/HQ, 
Geneva, 10–13 December 2007. Geneva, World Health Organization, 
2008 (WHO/HTM/NTD/WHOPES/2008.1; available at: 
http://whqlibdoc.who.int/hq/2008/WHO_HTM_NTD_WHOPES_2008.1
_eng.pdf; accessed January 2009). 
3 A generic risk assessment model for insecticide treatment and 
subsequent use of mosquito nets. Geneva, World Health Organization, 
2004 (WHO/CDS/WHOPES/GCDPP/2004.6; available at 
http://whqlibdoc.who.int/hq/2004/WHO_PCS_04.1.pdf; accessed 
January 2009). 
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1. inhalation exposure during sleeping under the net is 
negligible given the low vapour pressure of lambda-
cyhalothrin; 
2. adopts 0.0038 and 0.0025 mg/kg body weight as AELs 
for "acute" and "chronic" systemic exposure (values 
identical to those set by JECFA for long-term exposure 
to cyhalothrin1 and to that of the European Union for 
short-term and long-term exposures to lambda-
cyhalothrin2);  
3. uses 0.1% and 1% as the dermal absorption rates for 
the concentrated preparations and the dilutions of the 
insecticide. The values differ greatly from the default 
assumptions of the generic model, but the proposer 
justifies this by experimental data in vivo and in vitro 
from studies in animals and in humans. 
 
FIOH concluded that the characterization of the risks performed 
by the proposer closely follows the WHO generic model; where 
default assumptions are not accepted, justification mostly in the 
form of actual experimental data, are presented. The conclusion, 
in line with the generic model, is that no unacceptable 
exposures were found in maintenance and use of the nets, and 
that washing or sleeping under the LN does not pose undue risk 
to adults, children or newborns. 
 
 
6.2 Efficacy – WHOPES supervised trials 
 
6.2.1 Laboratory studies 
 
Montpellier, France 
Laboratory studies were conducted to determine the efficacy 
and wash resistance of the Lambda-cyhalothrin LN and to study 
the dynamics of the insecticide on the fibre following WHOPES 
guidelines.3 The evaluation included a determination of the time 
                                                          
1 WHO Food Additives Series 53: Cyhalothrin (addendum) 2004 
( available at 
http://www.inchem.org/documents/jecfa/jecmono/v53je04.htm. 
2 http://ec.europa.eu/food/plant/protection/evaluation/existactive/list1-
24_en.pdf).  
3 WHO (2005). Guidelines for laboratory and field testing of long-
lasting insecticidal mosquito nets. Geneva, World Health Organization 
(WHO/CDS/WHOPES/GCDPP/2005.11; available at: 
http://www.who.int/whopes/guidelines/en/; accessed January 2009). 
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required for full regeneration following washing and a 
determination of the wash resistance and efficacy of the 
Lambda-cyhalothrin LN against susceptible Anopheles gambiae 
mosquitoes (Duchon et al., 2008a). 
 
Four LNs were provided by the manufacturer for the evaluation.  
Two pieces of netting (25 cm x 25 cm) were cut from each net.  
Of these, four were used for a regeneration study and four were 
used in a wash resistance study. 
 
The procedures for net washing and bioassays were the same 
for assessing both regeneration time and wash resistance.  Net 
samples were washed by placing them in 1-litre beakers 
containing a soap solution of 0.5 L of deionized water with 2 g/L 
of soap (“Savon de Marseille”, pH 10–11).  The beakers were 
shaken for 10 minutes at 155 movements per minute and at 
30oC.  After 10 minutes, the samples were rinsed by placing 
them in clean deionized water (0.5 L) and shaking them for 10 
minutes in the same shaking conditions as above.  The rinsing 
procedure was repeated a second time and then the net 
samples were dried at room temperature for 2 hours before 
being stored in aluminum foil in the dark at 30 oC until their next 
wash. 
 
Bioassays were conducted using the WHO cone test method.  
Four WHO cones were attached to each piece of netting and 5 
Anopheles gambiae females (Kisumu strain, non-blood fed, 2–5 
days old) were introduced into each cone.  Mosquitoes were 
exposed for 3 minutes and then transferred to separate cages 
with access to sugar solution.  The process was repeated until 
a total of 50 mosquitoes had been exposed to each net sample.  
Knock-down was measured 60 minutes post-exposure while 
mortality was measured 24 hours post-exposure.  Results were 
pooled for analysis so that a total of 200 mosquitoes had been 
exposed at each time point.  Control bioassays were conducted 
on untreated nets (negative control) as well as on unwashed 
lambda-cyhalothrin treated nets (15 mg/m2). 
 
Regeneration time was estimated by washing 4 net samples 3 
times on consecutive days.  Bioassays were done on the nets 
before washing and then at 1, 3, and 5 days following the third 
wash.  Mortality was low, even on an unwashed sample (24%).  
After 3 washes, mortality was 28% at day 1 post-washing, 43% 
at day 3 and 41% at day 5.  Knock-down was 100% for an 
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unwashed LN and 98% at 1 day after the net samples had been 
washed 3 times.  At day 3 and day 5 post-washing, knock-down 
was 100%.  Based on these data, it was concluded that the 
regeneration time was 1 day.   
 
Wash resistance was done by washing four net samples as 
described above.  WHO cone bioassays were conducted after 0, 
1, 5, 10, 15 and 20 washes.  Washing was done five times per 
week and each bioassay was done just after the regeneration 
time and just before the next wash.  Mortality of mosquitoes 
exposed to the lambda-cyhalothrin LN samples ranged from 
24% to 64%.  Lowest mortality was observed at 0 wash while 
the highest mortality was observed after 10 washes.  By 20 
washes, mortality had fallen to 26%.  Knock-down was 100% 
through the experiment, regardless of the number of washes.  
Based upon the high knock-down in the WHO cone test after 20 
washes, the Lambda-cyhalothrin LN met the WHOPES criteria 
for Phase I testing (>80% mortality or >95% knock-down after 
20 washes) and further studies using the tunnel test were not 
required. 
 
Montpellier, France 
Since chemical analyses of net samples were not available in 
the previous study, a second set of laboratory studies was 
conducted on a new batch to determine the efficacy and wash 
resistance of the Lambda-cyhalothrin LN as well as to study the 
dynamics of the insecticide on the fibres (Finot et al., 2008).  
The manufacturer provided four LNs for the study.  Two pieces 
of netting (25cm x 25 cm) were cut from each net.  Four 
samples were used for the regeneration study and four were 
retained for the wash resistance study.  An additional 24 
samples were retained for chemical analysis. 
 
The net washing procedure followed that recommended by 
WHOPES guidelines.  Washing and bioassay were done as 
reported above.  
 
To estimate regeneration time, four net samples were washed 3 
times on consecutive days.  Bioassays were conducted on the 
nets before washing and then at 1, 3, 5, 7, and 10 days 
following the third wash.  Mortality was low, even on an 
unwashed sample (27%).  For net samples that had been 
washed three times, mortality in bioassays conducted 1, 3, 5, 7, 
and 10 days after washing ranged from 17% to 31%.  There 
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was no significant difference in mortality at different time points 
after washing and no evidence of increasing mortality with 
increasing time since washing.  Knock-down was 100% for an 
unwashed LN.  After 3 washes, knock-down was 100% at 1, 3, 
5, and 7 days post-washing.  Knock-down was 98% 10 days 
after the net samples had been washed 3 times.  Based on 
these data, it was concluded that the regeneration time was 1 
day.   
 
Wash resistance was done by washing four net samples as 
described above. WHO cone bioassays were conducted after 0, 
1, 5, 10, 15 and 20 washes.  Washing was done 5 times per 
week and each bioassay was done just after the regeneration 
time and just before the next wash.  Mortality of mosquitoes 
exposed to the lambda-cyhalothrin LN samples was 85% at 0 
wash.  Mortality fell to 53% after 1 wash.  Mortality continued to 
decline to 11% at 15 washes and 12% at 20 washes.  Knock-
down was >95% through 10 washes but fell to 86% at 15 
washes and 48% at 20 washes.  Unlike the previous study, the 
Lambda-cyhalothrin LN in this study did not meet the WHO 
efficacy criteria for Phase I testing by the cone test (>80% 
mortality or >95% knock-down after 20 washes) and additional 
tunnel tests were therefore performed. 
 
The tunnel test was conducted using a glass tunnel that was 60 
cm in length and had a cross-sectional area of 25 cm x 25 cm.  
At each end of the tunnel, a 25 cm square cage was fitted to the 
tunnel and covered with polyester netting to prevent the escape 
of mosquitoes.  At one third the length of the tunnel, a 
disposable cardboard frame was fitted with a net sample that 
had been washed 20 times.  The surface available to the 
mosquitoes was 20 cm x 20 cm with 9 holes, 1 cm in diameter 
cut into the netting to allow passage of mosquitoes.  In the 
shorter section of the tunnel, a guinea pig was restrained as a 
bait.  In the longer section of the tunnel, 100 female mosquitoes 
(Kisumu strain, non-blood fed, 5–8 days old) were released at 
18:00.  Females were free to move about the tunnel but had to 
land on the netting and locate the holes to pass through and 
feed upon the guinea pig.  At 09:00 the following morning, the 
mosquitoes were removed from each section of the tunnel and 
mortality and blood-feeding rates were recorded.  Two cages 
were run each night, one with test netting and one with 
untreated control netting.  Mortality was estimated as the total 
number of mosquitoes in the tunnel divided by the total number 
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released.  Blood-feeding inhibition was estimated as the 
proportion fed in the treated tunnel relative to the proportion fed 
in the control tunnel.  During the test, cages were held at 
27+2oC and 80+10% RH. 
 
After 20 washes, mortality of mosquitoes in the tunnel with the 
Lambda-cyhalothrin LN was 95%.  In the control tunnel, 
mortality was 11%.  In the tunnel with the Lambda-cyhalothrin 
LN, 47% of mosquitoes passed through the netting to the side 
with the guinea pig, compared to 99% of all mosquitoes 
released in the control tunnel.  Relative to the control tunnel, 
blood-feeding rates were reduced by 96% in the tunnel with the 
Lambda-cyhalothrin LN washed 20 times.  Based upon the 
tunnel test results, the Lambda-cyhalothrin LN washed 20 times 
met the criteria to continue to Phase II testing (mortality >80% 
and blood-feeding inhibition >95%). 
 
Chemical analysis (Pigeon 2008h) were performed on net 
samples washed 0, 1, 5, 10, 15 and 20 times. Per wash cycle, 
four pieces from 4 nets were analysed for determination of 
lambda-cyhalothrin content. The analytical method used 
involved extraction by heating under reflux with xylene and 
chromatographic determination by Gas Chromatography with 
63Ni Electron Capture Detection (GC-ECD) using the external 
standard calibration. The analytical method was successfully 
validated. 
 
Results of analysis for lambda-cyhalothrin content and retention 
(wash cure) are presented in Table 15 and figure 7. The 
between-net variation is expressed as the RSD of the content 
found on four pieces from different nets. Retention is calculated 
according to the Annex 1 of the report of the eleventh WHOPES 
Working Group Meeting, assuming a free migration stage 
behaviour (see Annex 1 of the Report of the eleventh WHOPES 
Working Group Meeting 1). 
 
                                                          
1 WHO (2008). Report of the eleventh WHOPES Working Group 
Meeting, WHO/HQ, Geneva 10–13 December 2007 
(WHO/HTM/NTD/WHOPES/2008.1; available at 
http://www.who.int/whopes/recommendations/wgm/en/; accessed 
January 2009). 
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The lambda-cyhalothrin content (1.33 g/kg) in the unwashed net 
complied with the target dose of 1.25 g/kg (± 25%) but the 
between-net RSD was high (24.5%). 
 
After 20 washes, the average lambda-cyhalothrin content was 
0.39 g/kg. The overall lambda-cyhalothrin retention after 20 
washes was 29% corresponding to an average retention per 
wash of 93%. 
 
 
6.2.2 Experimental hut studies 
 
Kou Valley, Burkina Faso 
Experimental hut studies were conducted in the Kou Valley of 
Burkina Faso to determine the efficacy of washed and 
unwashed Lambda-cyhalothrin LN in comparison with a net 
conventionally treated with lambda-cyhalothrin and to assess 
their impact on the behaviour of An. gambiae populations 
(Dabire et al., 2008a). 
 
The study area was situated in the Kou Valley, 30 km north of 
Bobo-Dioulasso.  The Kou Valley is a rice cultivation area 
surrounded by wooded savannah. Both molecular forms of An. 
gambiae s.s.  occur in sympatry but the S form increased in 
frequency (up to 85%), at the end of the rainy season (October-
November). Knock-down (kdr) mutation occurs in both forms 
but at different frequencies ( >90% in S form, around 20% for 
the M form) (Dabiré et al. 2008b; Pennetier et al., 2008). The 
trial was run from 9th of August till 12th of September 2007. 
 
Five treatment arms were included in the experiment: (I) 
untreated polyester net; (ii) lambda-cyhalothrin LN, unwashed; 
(iii) lambda-cyhalothrin LN, washed 20 times; (iv) polyester net, 
conventionally treated with lambda-cyhalothrin at 15 mg/m2, 
unwashed; and (v) polyester net, conventionally treated with 
lambda-cyhalothrin at 15 mg/ m2, washed until just before 
exhaustion (1 wash). All lambda-cyhalothrin LNs used in this 
study were of 100 denier. 
 
Nets were washed by study staff according to a standard 
protocol.  Nets were washed in aluminium bowls containing 10 
L of well water with 2 g/L of soap (Savon de Marseille).  Nets 
were agitated with a pole for 3 minutes at 20 rotations per 
minute, left to soak for 4 minutes and then agitated for an 
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additional 3 minutes.  After washing, the nets were rinsed twice 
in 10 L of clean water using the same procedure then dried 
horizontally in the shade. 
 
To determine the point of exhaustion of the conventionally 
treated nets, nets were washed as described above and 
bioassays were conducted after every wash.  Mortality fell 
below the threshold (80%) after just 2 washes, though knock-
down did not fall below the threshold (95%) until after 3 washes.  
However, knock-down had declined to just above the threshold 
after just 1 wash.  The point of exhaustion, defined as the 
maximum number of washes before a conventional net falls 
below the threshold, was therefore set at 1 wash. 
 
Five nets per treatment were used for the study.  The nets were 
bio-assayed on the day before washing, just after washing and 
at the conclusion of the study.  Bioassays were conducted with 
Anopheles gambiae, Kisumu strain.  Five WHO cones were 
fixed to each side of the net (top and 4 sides) and 5 female 
mosquitoes were introduced into each cone for 3 minutes.  A 
total of 50 mosquitoes were tested on each net.  Before 
washing, knock-down and mortality on the untreated polyester 
net were 0%.  Mortality was 94.7% and 91.8% on the 
conventionally treated nets and 76.7% and 77.6% on the 
lambda-cyhalothrin LNs.  Knock-down was 100% on all treated 
nets.  After washing, mortality fell to 82.4% and 80.3% on the 
unwashed and washed conventional nets.  Mortality was 74.0% 
and 20.6% on the unwashed and washed lambda-cyhalothrin 
LNs.  Knock-down was 100% on the treated nets, with the 
exception of the lambda-cyhalothrin LN where knock-down fell 
to 92.1% after washing 20 times. 
 
A sixth net in each treatment arm was used for chemical 
analysis.  Five pieces of netting (100 cm2) were taken from 
each side and roof of the nets for chemical analysis.  After 
washing, another 5 pieces were taken from each side and roof 
of the nets.  At the end of the study, 5 pieces of netting were 
taken from each side and roof of the nets used in the study for 
chemical analysis (Table 16).  The lambda-cyhalothrin content 
of nets before washing was 1.72 g/kg and 1.47 g/kg for the 
lambda-cyhalothrin LN (Pigeon 2008i). The target dose of a 100 
denier lambda-cyhalothrin LN is 1.25 g/kg and acceptable 
tolerance limits are 0.94 to 1.56 g/kg. For the conventionally 
treated nets, the lambda-cyhalothrin content was 0.36 g/kg.  
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After completion of the washing, the lambda-cyhalothrin content 
of the unwashed lambda-cyhalothrin LN was 1.75 g/kg while 
that of the lambda-cyhalothrin LN washed 20 times was 0.83 
g/kg corresponding to a retention of 47%.  The lambda-
cyhalothrin content was 0.33 g/kg for the unwashed 
conventional net and 0.10 g/kg for the conventional net washed 
1 time corresponding to a retention of 30%.  At the completion 
of the study, the lambda-cyhalothrin content was 0.85 g/kg (an 
outlier value) for the unwashed Lambda-cyhalothrin LN, 0.99 for 
the lambda-cyhalothrin LN washed 20 times, 0.28 g/kg for the 
unwashed conventional net, and 0.15 g/kg for the conventional 
net washed 1 time.  The RSD of lambda-cyhalothrin content 
before washing was 17.8% and 17.2% on the lambda-
cyhalothrin LNs.  The RSD for the conventionally treated nets 
before washing was 21.5% and 43.1%.  After the washings 
were completed but before the trial had started, the RSD was 
24.9% for the unwashed lambda-cyhalothrin LN and 7.9% for 
the washed lambda-cyhalothrin LN.  For the conventionally 
treated nets, the RSD was 14.3% for the unwashed net and 
21.0% for the net washed 1 time.  At the end of the study, the 
RSD was 83.1% (an outlier value) for the unwashed Lambda-
cyhalothrin LN, 33.0% for the washed lambda-cyhalothrin LN, 
16.7% for the unwashed conventional net and 11.2% for the 
conventional net washed 1 time. 
 
The experimental huts were constructed from concrete blocks 
with a corrugated iron roof, a ceiling of thick polyethylene 
sheeting, and a concrete base surrounded by a water filled 
channel to prevent the entry of ants.  Mosquitoes could enter 
the huts through 4 window slits constructed from pieces of 
metal and fixed at an angle to create a funnel with a 1 cm wide 
gap.  A veranda trap made of polyethylene sheeting and 
screening mesh, measuring 2 m long, 1.5 m wide and 1.5 m 
high, was located at the back of the hut to capture exiting 
mosquitoes.   
 
Nets used in the experimental hut study were deliberately holed 
to simulate a torn net.  Six holes 4 cm in diameter were made in 
each test net.  Adult volunteers slept under the nets and 
mosquitoes were collected each morning.  Mosquitoes were 
scored by location as well as whether they were dead or alive 
and fed or unfed.  Live mosquitoes were placed in cages and 
held for 24 hours to assess delayed mortality.  Sleepers and 
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nets were rotated randomly among the huts each night in a 
Latin square design. 
 
The primary outcomes measured in the experimental huts were: 
(i) deterrence (reduction in hut entry relative to the control huts); 
(ii) induced exophily (proportion of mosquitoes exiting early and 
found in the veranda traps); (iii) blood-feeding inhibition 
(reduction in blood-feeding compared with the control huts); and 
(iv) immediate and delayed mortality (proportion of dead 
mosquitoes). 
 
The experimental hut trial was run on 35 consecutive nights.  A 
total of 365 Anopheles gambiae were recorded in the control 
huts, of which 34.8% had exited early, 65.2% had blood fed and 
1.1% died.  There was no difference in the number of 
mosquitoes entering the control huts, the huts with an 
unwashed lambda-cyhalothrin LN or the huts with a polyester 
net washed to exhaustion.  Compared to the control huts, there 
were significantly fewer mosquitoes in the huts with the 
unwashed conventional net (deterrence=61.9%) and 
significantly more mosquitoes in the huts with a lambda-
cyhalothrin LN washed 20 times.  There were significantly more 
Anopheles gambiae in huts with the lambda-cyhalothrin LN 
washed 20 times compared to huts with a conventional net 
washed to exhaustion. 
 
The proportion of mosquitoes which exited huts with treated 
nets ranged from 60.9% to 72.7%.  For all treated nets, the rate 
of exit from huts was significantly higher than that observed in 
the control huts.  The rate of exit from huts with the 
conventional net washed to exhaustion was significantly lower 
than that observed for the other treated nets, including the 
lambda-cyhalothrin LN washed 20 times. 
 
The proportion of female mosquitoes which were blood fed was 
65.2% in the control huts.  In the huts with treated nets, the 
proportion blood fed ranged from 35.9% to 39.3%, 
corresponding to blood-feeding inhibition rates of 39.8% to 
45.0%.  The proportion blood fed in the control huts was 
significantly lower than the proportion fed in all huts with treated 
nets.  There were no differences in the proportion fed among 
huts with treated nets.  The proportion fed in the huts with the 
lambda-cyhalothrin LN washed 20 times was 39.2% which was 
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not significantly different from huts with the conventional net 
washed to exhaustion (proportion fed=36.9%). 
 
The mortality in huts with treated nets ranged from 16.0% to 
29.5%.  Mortality in all the huts with treated nets was 
significantly higher compared to the huts with untreated nets.  
Mortality in the huts with the lambda-cyhalothrin LN washed 20 
times was 19.5% and was not significantly different from the 
mortality observed in the hut with a conventional net washed to 
exhaustion (mortality=16.0%). 
 
Since the lambda-cyhalothrin LN washed 20 times performed 
as well as or better than a conventional net washed to 
exhaustion in terms of blood-feeding inhibition and mortality, it 
was concluded that the lambda-cyhalothrin LN met the criteria 
for Phase II testing of long-lasting insecticidal nets. 
 
Muheza, United Republic of Tanzania 
The efficacy of the lambda-cyhalothrin LN was evaluated in 
veranda trap experimental huts in Muheza (United Republic of 
Tanzania) against wild, free-flying Anopheles gambiae and 
Anopheles funestus (Tungu et al., 2008).  Six treatment arms 
were included in the study: (iv) lambda-cyhalothrin LN, 
unwashed; (ii) lambda-cyhalothrin LN, washed 20 times; (iii) 
lambda-cyhalothrin LN, washed to cut off (26 washes); (iv) 
polyester net, conventionally treated with lambda-cyhalothrin at 
15 mg/2, washed until just before exhaustion (2 washes); (v) 
polyester net, conventionally treated with lambda-cyhalothrin at 
15 mg/m2, washed 20 times; and (vi) untreated net. All lambda-
cyhalothrin LNs used in this study were of 100 denier. 
 
Three nets were used for each treatment arm.  Nets were 
washed according to a standard protocol.  Nets were placed in 
10 L of water with 2 g/L of soap (Savon de Marseille) and 
washed for a total of 10 minutes.  During the washing, the nets 
were agitated for 3 minutes, allowed to soak for 4 minutes and 
then agitated again for 3 minutes.  Agitation was done by 
stirring the net with a long pole at 20 rotations per minute.  The 
nets were then rinsed twice in 10 L of water and dried between 
washings. 
 
The point of exhaustion was determined by conducting 
bioassays after each wash.  The point of exhaustion was 
defined as the maximum number of washes a net could 
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withstand before mortality of mosquitoes exposed in standard 
WHO cone assays fell below 80% and knock-down fell below 
95%.  Cone bioassays using Anopheles gambiae (Kisumu 
strain) showed that knock-down on the conventionally treated 
net fell below 95% after the first wash.  Mortality fell below 80% 
after 3 washes.  The point of exhaustion for the conventionally 
treated net was therefore set at 2 washes.  The point of 
exhaustion was also determined for the lambda-cyhalothrin LN.  
For this net, knock-down fell below 95% after 5 washes while 
mortality fell below 80% after 26 washes.  The point of 
exhaustion for the lambda-cyhalothrin LN was therefore set at 
26 washes. 
 
Cone bioassays were conducted on all nets that were used in 
the experimental hut study.  The bioassays were done just 
before the washings, just after the washings and at the end of 
the trial.  Just before the washings, knock-down and mortality 
were 100% on all treatment arms except the untreated net, 
where knock-down and mortality were 0%.  After the washing of 
nets was completed, knock-down fell to 92% on the 
conventional net washed 2 times, 14% on the conventional net 
washed 20 times, 86% on the lambda-cyhalothrin LN washed 
20 times, and 68% on the lambda-cyhalothrin LN washed 26 
times.  Mortality on these same nets was 95% for the 
conventional net washed 2 times, 32% for the conventional net 
washed 20 times, 92% for the lambda-cyhalothrin LN washed 
20 times and 78% for the lambda-cyhalothrin LN washed 26 
times.  At the end of the experimental hut study, knock-down 
fell to 46% on the conventional net washed 2 times, 2% for the 
conventional net washed 20 times, 90% on the lambda-
cyhalothrin LN washed 20 times and 76% for the lambda-
cyhalothrin LN washed 26 times.  Mortality on these nets was 
24% for the conventional net washed 2 times, 10% for the 
conventional net washed 20 times, 80% for the lambda-
cyhalothrin LN washed 20 times and 52% for the lambda-
cyhalothrin LN washed 26 times. 
 
One net in each treatment arm was not tested in the huts but 
used for chemical analysis by gas chromatography.  Eighteen 
pieces were cut from each net (3 or 4 pieces taken from each 
side and roof of the net) before any washing was done.  After 
washing was completed, an additional 18 pieces were cut from 
each net.  At the end of the trial, 18 pieces were cut from one 
net in each arm of the study (Table 16).  Before washing was 
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conducted, lambda-cyhalothrin content ranged from 1.42 to 
1.60 g/kg (57.2 to 68.9 mg/m2) for the lambda-cyhalothrin LNs 
and from 0.16 to 0.19 g/kg (6.7 to 7.8 mg/m2) for the 
conventionally treated nets (Pigeon 2008j).  One of the three 
unwashed nets was outside acceptable tolerance limits (0.94 to 
1.56 g/kg). After washing, lambda-cyhalothrin content on the 
lambda-cyhalothrin LN washed 20 times fell to 0.63 g/kg (28.2 
mg/m2) while that on the lambda-cyhalothrin LN washed 26 
times fell to 0.47 g/kg (19.6 mg/m2).  For the conventionally 
treated nets washed 2 or 20 times, lambda-cyhalothrin content 
after washing was 0.02 g/kg (0.7 mg/m2) and <0.01 g/kg (<0.4 
mg/m2), respectively.  At the conclusion of the study, the 
lambda-cyhalothrin content on the unwashed Lambda-
cyhalothrin LN remained unchanged at 1.43 g/kg (62.0 mg/m2).  
Regular use of the lambda-cyhalothrin LN did not affect the 
washed nets either.  At the end of the study, the lambda-
cyhalothrin content on nets washed 20 or 26 times was 0.60 
g/kg (25.4 mg/m2) and 0.44 g/kg (17.9 mg/m2), respectively.  
Lambda-cyhalothrin content on the conventionally treated nets 
washed 2 or 20 times was 0.01 g/kg (0.5 mg/m2) and <0.01 g/kg 
(<0.4 mg/m2), respectively.  Before the washings were 
completed, the within-net RSD in lambda-cyhalothin content of 
the unwashed lambda-cyhalothrin LN was 21.5%.  The RSD of 
the lambda-cyhalothrin LN to be washed 20 times was 16.9% 
and the RSD of the lambda-cyhalothrin LN to be washed 26 
times was 21.9%.  The RSD of the conventional net to be 
washed 2 times was 44.1% and the RSD of the conventional 
net to be washed 20 times was 61.3%.  After the washings 
were completed, the RSD of the unwashed lambda-cyhalothrin 
LN was 29.4%, the RSD of the lambda-cyhalothrin LN washed 
20 times was 38.6% and the RSD of the lambda-cyhalothrin LN 
washed 26 times was 19.6%.  The RSD of lambda-cyhalothrin 
content on the conventionally treated nets after washing 2 times 
was 5.3%.  After washing 20 times, the lambda-cyhalothrin was 
below the quantification limits so no RSD was given.  At the end 
of the hut trial, the RSDs of the lambda-cyhalothrin LNs that 
were washed 0, 20 or 26 times were 13.4%, 22.1% and 20.3%, 
respectively.  The RSD of the lambda-cyhalothrin content on 
the conventionally treated net washed 2 times was 11.1%. 
 
Six experimental huts were used in the study.  The huts were 
the traditional east African veranda trap design.  The huts were 
made of concrete walls smeared with mud and an iron roof with 
a wooden ceiling lined with hessian cloth.  The eaves were 
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open on all sides to allow passage of mosquitoes.  Two 
verandas on opposite sides were screened to capture 
mosquitoes that exited through the eaves or windows while the 
verandas on the remaining two sides were left open to allow for 
mosquito entry.  The screens on the verandas were rotated 
periodically to reduce any biases introduced by the position of 
the veranda screens.  The huts were built on concrete plinths 
and surrounded by a water filled moat to prevent the entry of 
ants or other scavengers. 
 
Volunteers slept under nets in the huts on 36 nights over 6 
weeks.  The nets were deliberately holed to simulate a torn net.  
Six holes, 4 cm x 4 cm were cut in each net, with 2 holes on 
each long side of the net and 1 hole at each end.  The three 
nets per treatment arm and the sleepers were rotated through 
the huts in a Latin square design.  Each net was tested in each 
hut on at least 2 nights.  Mosquitoes were collected each 
morning from the floors, walls, exit traps and inside the nets and 
scored as dead or alive, fed or unfed.  Live mosquitoes were 
held for 24 hours to assess delayed mortality.  For data analysis, 
the number of mosquitoes captured in the veranda traps was 
doubled to account for mosquitoes escaping through the open 
verandas. 
 
The trial took place between 31 March and 10 May 2008. An 
average of 24.7 An. gambiae females were captured each night 
in the huts with untreated nets.  For huts with treated nets, the 
number of mosquitoes entering each night ranged from 14.5 to 
22.3.  There were significantly fewer Anopheles gambiae in the 
huts with treated nets compared to the huts with untreated nets.  
There was no difference in the number of Anopheles gambiae 
entering huts with a lambda-cyhalothrin LN washed 20 times 
(16.6 females per night) compared to huts with a conventional 
net washed to the point of exhaustion (17 females per night).  
An average of 4.2 female An. funestus were captured in the 
huts with untreated nets during the study.  This was significantly 
higher than the number of Anopheles funestus captured in huts 
with all other treatments except for huts with conventional nets 
washed until exhaustion (3.7 An. funestus per night).  The 
number of female An. funestus captured in the huts with 
conventional nets treated to the point of exhaustion was 
significantly higher than the number captured in huts with the 
lambda-cyhalothrin LN washed 20 times (2.3 An. funestus per 
night). 
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There was a high rate of exophily among all treatment groups 
for both An. gambiae and An. funestus.  For An. gambiae, 77% 
of all mosquitoes were captured in the exit traps in huts with the 
untreated nets.  This was significantly lower than the proportion 
that were captured in the veranda traps in the other treatment 
arms where exophily ranged from 88.5% to 94.9%.  There was 
no difference in the rate of exophily in huts with the lambda-
cyhalothrin LN washed 20 times (91.8%) compared to the 
conventionally treated net washed to exhaustion (93.6%).  For 
An. funestus, 79.6% of mosquitoes collected in huts with 
untreated nets were captured in the veranda traps.  This was 
significantly lower compared to all other treatment groups 
except the lambda-cyhalothrin LN washed 20 times (86.6%).  
The rate of exophily in the huts with the lambda-cyhalothrin LN 
washed 20 times was significantly lower than that observed in 
huts with a conventional net washed to the point of exhaustion 
(95.5%). 
 
In huts with untreated nets, 32.1% of An. gambiae were blood 
fed.  There were significantly more blood fed An. gambiae in 
huts with untreated nets compared to all other treatment groups 
where the percent of mosquitoes that were fed ranged from 
8.7% to 19.7%.  Blood-feeding inhibition ranged from 38.8% to 
72.9%.  The proportion of An. gambiae that were fed in huts 
with the lambda-cyhalothrin LN washed 20 times (13.7%) was 
not significantly different from the proportion that were fed in 
huts with conventional nets washed to exhaustion (13.9%).  For 
An. funestus, 24.3% of females were fed in the huts with 
untreated nets.  The proportion fed in the control huts was 
significantly higher than all other treatments except for the huts 
with the 20 times washed lambda-cyhalothrin LN where 18.3% 
of female An. funestus were blood fed.  Blood-feeding inhibition 
ranged from 24.7% to 63.2%.  The proportion of blood fed An. 
funestus in the huts with the lambda-cyhalothrin LN washed 20 
times was not significantly different from the proportion blood 
fed in huts with the conventional net washed to the point of 
exhaustion (9.0%). 
 
Mortality of An. gambiae was 11.8% in the huts with untreated 
nets.  This was significantly lower than the mortality observed in 
all other treatments.  The overall killing effect for the treated 
nets ranged from 30.9% to 47.2%.  For huts with the lambda-
cyhalothrin LN washed 20 times, mortality was 87.5% and was 
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significantly higher than the mortality rate in huts with the 
conventional net washed to exhaustion (65.9%).  For 
Anopheles funestus, mortality in the huts with untreated nets 
was 15.1%, which was significantly lower than the mortality 
observed in all other treatment arms.  The overall killing effect 
for Anopheles funestus ranged from 26.3% to 46.1%.  The 
mortality of Anopheles funestus in huts with the lambda-
cyhalothrin LN washed 20 times was 84.1% which was 
significantly greater than the mortality of Anopheles funestus in 
huts with the conventional net washed to the point of 
exhaustion (56.7%). 
 
The lambda-cyhalothrin LN washed 20 times showed similar 
efficacy in terms of blood-feeding inhibition for both Anopheles 
gambiae and Anopheles funestus compared to a conventional 
net washed to the point of exhaustion.  In terms of mortality and 
killing effect, the lambda-cyhalothrin LN washed 20 times 
showed greater efficacy against both Anopheles gambiae and 
Anopheles funestus compared to a conventional net washed to 
exhaustion.  It was therefore concluded that the lambda-
cyhalothrin LN met the criteria for Phase II testing. 
 
 
6.3 Conclusions and recommendations 
 
The lambda-cyhalothrin LN of Syngenta, Switzerland (= ICON  
MAXX-Net), is a factory-produced polyester mosquito net 
treated with the slow-release capsule suspension of lambda-
cyhalothrin, ICON  10 CS. The insecticide is coated on 
polyester netting at the target dose of 50 mg AI/m2, using a 
polymer as a binder. Lambda-cyhalothrin CS has previously 
been evaluated by WHOPES and has been recommended for 
treatment of mosquito nets.1 
 
The manufacturer has disclosed the nature of the binder used 
in coating the LN and has confirmed that it is the same as the 
                                                          
1 Report of the fourth WHOPES Working Group Meeting, WHO/HQ, 
Geneva, 4–5 December 2000. Geneva, World Health Organization, 
2001 (WHO/CDS/WHOPES/2001.4; available at: 
http://whqlibdoc.who.int/hq/2001/WHO_CDS_WHOPES_2001.4.pdf; 
accessed January 2009). 
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binder used in making ICON MAXX mosquito net treatment kits1 
already subject to the WHO safety assessment. 
 
The WHO assessment of the compliance of the manufacturer’s 
assessment of exposure to and risks of washing and sleeping 
under a lambda-cyhalothrin LN was in line with the WHO 
generic risk assessment model although some default values of 
the guideline were not used but appropriately justified. The 
assessment concluded that washing or sleeping under the LN 
does not pose undue risk to adults, children or newborns. 
 
The performance of two batches of lambda-cyhalothrin LN in 
standard laboratory testing in the same WHO collaborating 
centre was different. In one study the mortality in WHO cone 
bioassays was consistently below the efficacy criteria while 
knock-down was 100% through 20 washes. In the second study 
mortality fell below the criteria after just one wash and knock-
down fell below the criteria after 15 washes. However in the 
second study the tunnel test performed on nets washed 20 
times met the WHOPES criteria.   
 
Field studies demonstrated a better or equal impact of the 
lambda-cyhalothrin LN washed 20 times on mortality and blood-
feeding inhibition of prominent malaria vectors compared with 
that of conventionally treated polyester nets (15 mg/m² lambda-
cyhalothrin) washed until just before exhaustion. This confirms 
that the lambda-cyhalothrin LN fulfils the WHOPES main 
efficacy criteria of Phase II studies.   
 
Chemical analysis of the lambda-cyhalothrin LN, however, 
indicated high within and between-net variability.  The within-net 
RSD of the lambda-cyhalothrin content of an unwashed 
lambda-cyhalothrin LN ranged from 16.9% to 29.4% in 2 
separate studies (Table 16).  The between-net RSD of the 
lambda-cyhalothrin content of the unwashed lambda-
cyhalothrin LN was 24.5% in one study.  Furthermore, the 
lambda-cyhalothrin content of 3 of 6 nets tested exceeded the 
target dose by >25% in WHOPES Phase II trials.  According to 
                                                          
1 Report of the eleventh WHOPES Working Group Meeting, WHO/HQ, 
Geneva, 10–13 December 2007. Geneva, World Health Organization, 
2008 (WHO/HTM/NTD/WHOPES/2008.1; available at: 
http://whqlibdoc.who.int/hq/2008/WHO_HTM_NTD_WHOPES_2008.1
_eng.pdf; accessed January 2009). 
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the WHO guidelines, the acceptable within-net variability of the 
AI should not exceed 5% RSD when five pieces of 25 cm x 25 
cm are analyzed as a single sample.  Moreover, the average AI 
content between nets should not exceed + 25% of the declared 
AI content1.    
 
Noting the above, the meeting concluded: 
 
  that the high within-net and between-net variability in the 
content of lambda-cyhalothrin may affect its 
performance under routine domestic use over the 
lifetime of the net. This will also impact the development 
of standards and methods for quality control of this 
product. The manufacturer is therefore urged to reduce 
the variability of lambda-cyhalothrin content in 
conformity with limits recommended by WHO.   
  
                                                          
1 FAO/WHO (2006). Manual on development and use of FAO and 
WHO specifications for pesticides. Revised first edition, Rome, Food 
and Agriculture Organization of the United Nations (available at 
http://www.who.int/whopes/quality/en/; accessed January 2009). 
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7. GENERAL RECOMMENDATIONS 
 
The twelfth WHOPES working group meeting made the 
following general recommendations: 
 
- that as part of the Phase III evaluation of all types of 
LNs, WHOPES should commission cross-sectional 
surveys from multiple countries in addition to 
supervised longitudinal studies recommended in 
WHOPES guidelines; 
 
- that the research community should conduct Phase 
II experimental hut studies of nets that have been 
used under routine household use for several years 
with varying levels of bio-efficacy and varying 
numbers of holes to better understand the long-term 
effectiveness of LNs;  
 
- that WHOPES should develop guidelines to evaluate 
durability as part of Phase III supervised longitudinal 
studies and cross-sectional surveys of LNs that are 
in household use for three years; 
 
- that LN manufacturers should provide all LNs with 
wash-resistant labels (tags) indicating the date of 
manufacture, denier and other information as 
recommended by WHO;  
 
- that the research community and other stakeholders 
should develop methods and criteria for the 
evaluation of resistance-breaking tools. 
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ANNEX III.  QUESTIONNAIRE - WHOPES LARGE-SCALE 
TESTING AND EVALUATION OF PERMANET 2.0 
 
 
Five digit survey code (first two digits country; one digit 
village; two digits for sample: -------------------  
 
 
Country ………………………   
Province …………………….   
District …………………… … 
Village ………………………..  
nearest town …………………… 
 
 
Date of survey (DD/MM/YY) …………………………………. 
 
 
Specify exact location of household in the village ……………… 
………………………………………………………………………. 
 
 
Batch number of the net sampled  (if readable)……………….  
(attach the LN label to the form) 
 
 
Date of production of the net (if 
readable) ……………………………. 
 
 
Information on net usage provided by: 
  1) User of this net 
  2) Caretaker of those using the net 
  3) Head of household 
  4) Other (specify) …………………………… 
 
 
Date of receipt/purchase of the net: -------------- (months) 
 
 
Information on net usage: 
  1) Year-round and every night. 
  2) Year-round but occasionally. 
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  3) Seasonally but every night. 
  4) Seasonally and occasionally 
 
 
How is the net used? 
  1) Hanging over the bed 
2) Hanging over sleeping mat/mattress on the 
ground 
  3) Other (specify) …………………………… 
 
 
How did you get the net ? 
1) Paid or purchased yourself? 
2) Given free 
3) Specify  
 
 
How the net was last washed? …………………………………… 
 
 
When was the last time you washed the net? …………(month) 
 
 
How frequently you wash the net? …………………(month) 
 
 
How many times a net is washed in a year time? ……… times 
 
 
How was the net last washed? 
 
  Water:   
1) cold …. 2) warm …. 3) hot ….  
   
Soap: 
 1) village (local)-made soap 
 2) Commercial bar 
 3) Commercial powder 
 4) mix of soap and powder 
 
Soaking: 
 1) yes ….  2) No ….  
 If yes, how long? ……. (Hour) 
 118 
 
Rinsing: 
 1) yes …. 2) No ….  
   
  Rubbing against rocks/stone: 
 1) yes …. 2) No ….  
 
  Where net was dried: 
   1) inside …  2) outside 
 
 
 
Physical Inspection of the net 
 
Net is found to have holes   
1) Yes …  2) No … 
   
 
If yes, use the following code for sizes of holes 
 1) hole smaller than will allow a thumb to pass through 
2) a larger hole, but will not allow a closed fist to pass 
through 
3) hole bigger than a closed fist 
 
 
Total number of holes: 
   …….. total size 1 
   …….. total size 2 
   …….. total size 3 
 
 
Total number of holes: 
   …….. lower half of the net 
…….. upper half of the net 
…….. roof  
 
 
Total number of open/failed seams using the size coding 
provided above: 
   …….. total size 1 
   …….. total size 2 
   …….. total size 3 
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Total number of repairs: 
   # ….. with stitches 
   # ….. with knots 
   # ….. with patches 
 
  
Total number of holes due to burns? # ………  
 
 
Presence of patches, nods or apparent repairs on the net 
 
   
Aspect of net: 
   1) clean 
   2) a bit dirty 
   3) dirty 
   4) very dirty 
 
 
 
Name and signature of 
investigator  ………………………………………………… 
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Figure 1 Sample preparation for determination of deltamethrin 
content and biological assays (position 1 was ignored as it may 
have been subjected to excessive abrasion and is the part that is 
supposed to be tucked under the mattress) 
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